data_2ita_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ita _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 3.2 tt -75.56 -37.63 59.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -39.74 94.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.35 -18.14 53.05 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.418 ' N ' HD11 ' A' ' 21' ' ' LEU . 5.6 t90 -84.43 -42.91 15.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' A' ' 27' ' ' MET . 69.1 t -63.22 -32.7 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.213 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.63 -26.67 41.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.755 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -61.41 -42.77 99.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.1 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.61 -29.7 17.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.68 0.752 . . . . 0.0 109.714 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.597 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.92 -31.85 69.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.181 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.1 ttp -93.01 -41.2 10.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.087 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 25' ' ' PHE . 9.5 mtpt -91.4 -58.16 2.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -51.76 -27.2 19.27 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.859 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.699 0.285 . . . . 0.0 111.314 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.8 m -84.54 -47.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.66 -40.77 84.44 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.767 0.318 . . . . 0.0 110.63 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -71.76 -28.67 63.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 4.9 tp -72.39 -39.23 68.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.005 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.63 -49.56 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.94 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.45 71.02 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 10.8 t80 -86.37 -33.02 20.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.2 m-85 -76.56 -31.54 57.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.96 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -81.4 -29.59 33.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.55 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.518 -0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.297 179.51 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' CG ' ' H ' ' A' ' 19' ' ' LEU . 5.7 p30 . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' CG ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -75.78 -42.59 49.77 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.0 111.15 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.608 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -71.82 -31.72 66.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.748 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.55 -22.49 43.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.419 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.479 ' N ' HD12 ' A' ' 21' ' ' LEU . 40.5 t90 -82.21 -48.36 11.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 20' ' ' ARG . 12.0 p -65.31 -30.67 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.333 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 20' ' ' ARG . . . -83.5 -26.8 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -58.23 -38.88 77.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.712 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.13 -30.57 16.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.476 0.655 . . . . 0.0 110.519 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.73 -34.96 76.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.823 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -34.88 13.17 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.59 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 7.5 ttpp -98.22 -33.89 10.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -84.24 -9.27 82.34 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.67 0.271 . . . . 0.0 111.612 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.537 ' O ' HD23 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.4 m -82.39 -52.19 7.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.844 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 46' ' ' GLY . 58.2 mt -57.45 -36.59 71.61 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.444 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -72.19 -30.74 65.25 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 3.1 tp -73.06 -50.06 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 mt -82.92 -46.35 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.012 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -64.41 -34.32 89.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 21.7 t80 -76.69 -33.17 58.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.207 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -75.46 -32.9 60.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.531 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -29.46 66.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 46' ' ' GLY . 14.0 t . . . . . 0 C--O 1.221 -0.413 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 8.8 m-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 ' C ' ' N ' ' A' ' 21' ' ' LEU . 2.9 tt -75.85 -52.85 9.47 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.292 0.568 . . . . 0.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -53.48 -16.18 1.37 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.817 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' N ' ' C ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -77.15 -62.86 1.51 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.155 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -64.47 -43.27 94.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.837 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 27' ' ' MET . 22.0 t -56.58 -35.58 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.731 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 28' ' ' MET . . . -79.68 -26.74 40.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.6 -37.47 78.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.61 -41.78 10.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 111.63 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -69.21 -39.57 78.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.39 -179.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -92.68 -41.83 9.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.751 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 23.8 mtmt -97.08 -29.72 13.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.484 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -87.7 -5.2 78.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.777 0.322 . . . . 0.0 111.706 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.573 ' O ' HD13 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 m -84.39 -47.06 11.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.53 0.205 . . . . 0.0 110.622 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.8 mt -58.87 -34.97 72.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.625 HD12 HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.22 -33.05 67.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.683 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -73.0 -44.06 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.462 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.22 -42.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -67.29 -30.47 75.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -83.45 -33.1 25.73 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 109.894 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -77.1 -31.47 55.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.905 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -29.77 56.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.917 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.44 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 37.9 m-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.5 tp -75.16 -32.73 61.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.503 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -33.61 76.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -83.46 -30.78 26.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.265 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.94 -44.71 76.2 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 27' ' ' MET . 52.6 t -64.48 -33.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.195 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.62 -26.78 41.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -43.44 89.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.67 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -89.68 -28.47 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.431 0.634 . . . . 0.0 110.14 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.647 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.42 -31.89 71.55 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.528 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 ttp -92.55 -33.4 14.46 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.097 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.95 -18.99 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 110.19 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -103.33 -9.67 38.19 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.943 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.647 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 0.0 111.651 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.533 ' O ' HD12 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -85.64 -45.05 12.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.823 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 46' ' ' GLY . 9.7 mt -60.9 -35.9 77.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 110.523 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -72.56 -31.88 65.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 1.3 tp -72.45 -45.23 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.507 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.9 mt -85.7 -41.8 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -68.62 -31.15 73.15 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.646 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 42.0 t80 -79.95 -32.44 39.98 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.91 0.386 . . . . 0.0 110.467 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.37 -51.98 10.82 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -29.72 68.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.173 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.72 -52.88 8.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.89 -31.94 73.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.21 -26.19 42.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.692 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -82.28 -37.7 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 27' ' ' MET . 84.5 t -63.5 -37.14 78.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.611 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.61 -26.79 41.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.801 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -63.28 -35.67 81.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.209 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.59 -40.28 11.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.222 0.534 . . . . 0.0 111.108 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.595 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.2 -43.22 67.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.339 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.6 ttp -92.35 -41.73 10.19 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.551 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.801 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 1.7 ttpt -96.07 -32.38 12.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -85.01 -4.13 87.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.38 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.567 ' O ' HD22 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 m -82.5 -46.21 13.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 0.0 110.415 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLY . 5.2 mt -60.4 -38.09 82.89 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.612 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -71.92 -28.9 63.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.6 tp -72.85 -44.79 60.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.945 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 mt -87.85 -49.5 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.29 -24.33 65.36 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.565 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 6.5 t80 -88.86 -33.05 17.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.975 0.417 . . . . 0.0 110.106 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -32.86 64.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -34.12 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.713 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.376 -179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 4.8 m-80 . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.29 62.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.304 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.04 -38.96 92.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' CD2' ' O ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -79.02 -23.1 44.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.738 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.471 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -76.96 -55.23 5.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -57.45 -29.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.34 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' HA ' ' CG ' ' A' ' 27' ' ' MET . . . -78.35 -26.08 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.097 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -71.37 -30.27 65.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.099 -179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.87 -37.48 12.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 112.037 -179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.614 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -65.32 -37.19 86.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.298 0.571 . . . . 0.0 111.163 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.7 ttp -92.71 -41.59 10.07 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.113 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 3.2 mtmm -95.4 -43.99 7.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.115 0.483 . . . . 0.0 110.096 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -70.63 -13.14 71.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.114 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.333 -0.129 0 CA-C-O 120.766 0.317 . . . . 0.0 111.547 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.557 ' O ' HD23 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.1 m -84.61 -48.28 9.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.684 0.278 . . . . 0.0 110.703 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 46' ' ' GLY . 22.2 mt -58.66 -36.64 74.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.14 -31.9 66.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -72.63 -45.87 56.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.87 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 mt -87.73 -48.57 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.67 -28.79 72.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -84.86 -33.26 22.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -73.05 -35.9 66.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -75.72 -32.85 60.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.408 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 47' ' ' PHE . 9.8 p . . . . . 0 C--O 1.222 -0.352 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.469 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 9.2 m-80 . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.6 tp -74.04 -31.18 62.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.824 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -61.87 -39.49 92.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.493 HD11 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.44 -30.83 42.41 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.092 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.435 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 5.9 t90 -71.1 -41.13 70.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 27' ' ' MET . 70.4 t -67.64 -31.58 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.147 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.7 -26.67 40.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.627 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -70.64 -31.72 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.722 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -92.06 -29.15 16.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.763 0.792 . . . . 0.0 109.798 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.573 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.03 -34.0 74.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.805 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.7 ttp -94.19 -40.18 10.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.148 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -95.08 -39.25 10.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.492 0.663 . . . . 0.0 110.625 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -79.34 -13.31 82.89 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.598 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.309 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 m -83.08 -44.67 14.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.683 0.278 . . . . 0.0 110.635 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 4.8 mt -60.82 -35.5 76.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.861 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.714 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -72.59 -30.32 64.28 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 6.3 tp -72.93 -50.18 25.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.028 0.442 . . . . 0.0 110.927 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -81.48 -47.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.587 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.36 -23.56 64.64 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.714 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 64.6 t80 -81.54 -33.7 31.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -32.55 39.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -32.43 62.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.469 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.192 0.52 . . . . 0.0 111.743 179.876 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.2 t30 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.405 ' C ' ' N ' ' A' ' 21' ' ' LEU . 1.5 tp -76.1 -53.03 8.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -17.99 1.36 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.816 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' A' ' 19' ' ' LEU . 1.2 mm? -77.94 -63.18 1.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 4.5 t90 -61.11 -44.48 97.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.845 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 27' ' ' MET . 26.3 t -51.37 -31.84 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.37 41.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.847 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.822 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.04 -29.35 70.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.551 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.15 -37.09 13.59 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.891 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.97 -36.66 23.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.261 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.4 ttp -91.9 -43.61 9.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.828 0.347 . . . . 0.0 111.205 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.3 mtmt -93.8 -31.18 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.13 0.59 84.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.41 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.69 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' O ' HD21 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 84.9 m -84.34 -46.25 11.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.243 . . . . 0.0 110.657 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 46' ' ' GLY . 3.1 mt -60.57 -38.58 85.05 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -71.94 -29.14 63.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 2.5 tp -72.95 -48.23 38.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.907 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.32 -48.17 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.329 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -62.26 -33.6 86.55 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.301 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.15 -32.82 44.43 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -40.03 49.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -28.88 67.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 46' ' ' GLY . 93.0 t . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.6 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 1.1 m120 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.975 0.417 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -76.17 -43.02 44.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.86 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -52.48 -29.97 27.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.673 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 18' ' ' ASN . 4.2 pp -78.7 -41.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.887 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 24.5 t90 -61.96 -45.31 94.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.665 ' O ' ' HB3' ' A' ' 27' ' ' MET . 13.0 t -60.28 -30.18 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.342 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.21 -26.79 42.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.938 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -45.61 92.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.893 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.54 -28.57 18.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 179.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.665 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.99 -31.61 70.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.838 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -38.78 11.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.563 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -50.79 5.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 109.53 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -63.43 -20.68 63.7 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.492 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 43' ' ' LEU . . . . . . . . 0 CA--C 1.518 0.265 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.7 m -82.35 -53.35 6.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.181 0.515 . . . . 0.0 110.734 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -49.98 -45.58 51.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.344 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.641 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -72.11 -30.41 65.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.718 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.443 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 3.6 tp -73.06 -47.45 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.044 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mt -80.51 -46.58 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.539 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -66.13 -43.22 93.68 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 14.0 t80 -66.66 -32.85 74.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.094 0.474 . . . . 0.0 109.86 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 4.4 m-30 -75.35 -30.3 60.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.947 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.07 -28.97 57.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 46' ' ' GLY . 2.5 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.58 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 23.2 m-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.979 0.419 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 21' ' ' LEU . 1.2 tp -75.61 -52.36 10.75 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.427 0.632 . . . . 0.0 110.083 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -52.36 -16.76 0.93 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.746 178.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' N ' ' C ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -77.58 -63.07 1.46 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.793 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.26 -34.29 77.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.821 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.633 ' O ' ' HB3' ' A' ' 27' ' ' MET . 40.3 t -65.5 -34.14 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.658 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.58 -26.9 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -42.3 99.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.959 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 pt20 -91.07 -28.9 17.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.088 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.633 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.967 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.5 ttm -93.45 -41.66 9.68 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.09 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.62 -39.75 10.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.413 0.625 . . . . 0.0 110.41 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -80.72 -8.2 87.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.846 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' O ' HD21 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.8 m -81.61 -53.77 5.97 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.061 0.458 . . . . 0.0 111.218 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -50.31 -44.07 54.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.603 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -71.93 -31.51 66.42 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 2.6 tp -73.21 -49.99 24.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.389 0.614 . . . . 0.0 110.691 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.01 -52.14 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.141 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -60.58 -28.88 68.42 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.607 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 28.5 t80 -79.66 -32.98 41.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.061 0.458 . . . . 0.0 110.014 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -31.92 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -29.87 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.648 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.509 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.894 0.378 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.11 146.73 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -179.37 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.986 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.55 129.72 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p 44.36 37.79 2.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.841 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.8 133.46 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 111.377 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -161.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -149.71 113.99 5.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.875 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.61 -88.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -90.35 -89.34 0.16 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.83 5.39 4.25 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -105.84 178.58 4.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.801 0.334 . . . . 0.0 110.819 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.4 -88.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 3.4 p-10 172.41 62.33 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.605 0.241 . . . . 0.0 110.934 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 5.5 Cg_exo -77.31 -16.27 15.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.721 2.28 . . . . 0.0 112.382 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.1 -56.73 3.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.728 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' CD1' ' A' ' 21' ' ' LEU . 77.9 m -61.79 -27.65 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.839 0.352 . . . . 0.0 110.61 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -61.79 -66.58 0.52 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.496 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 3.2 tt -75.56 -37.63 59.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -64.66 -39.74 94.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.35 -18.14 53.05 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.418 ' N ' HD11 ' A' ' 21' ' ' LEU . 5.6 t90 -84.43 -42.91 15.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' A' ' 27' ' ' MET . 69.1 t -63.22 -32.7 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.213 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.63 -26.67 41.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.755 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -61.41 -42.77 99.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.1 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.61 -29.7 17.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.68 0.752 . . . . 0.0 109.714 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.597 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.92 -31.85 69.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.181 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.1 ttp -93.01 -41.2 10.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.087 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 25' ' ' PHE . 9.5 mtpt -91.4 -58.16 2.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -51.76 -27.2 19.27 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.859 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -76.38 -26.58 55.78 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.699 0.285 . . . . 0.0 111.314 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.87 -7.37 70.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.973 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -83.95 -72.14 0.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.837 0.319 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.29 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.849 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . -56.76 -49.04 73.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.878 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' O ' ' HA3' ' A' ' 40' ' ' GLY . . . -85.06 -31.67 22.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.75 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.7 t -75.37 -55.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.367 0.603 . . . . 0.0 110.37 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 9.8 t80 -73.82 -58.54 3.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.961 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -69.1 -41.84 76.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 36' ' ' GLY . . . -58.24 -29.36 62.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.148 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.8 m -84.54 -47.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 38' ' ' PHE . 14.7 mt -58.66 -40.77 84.44 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.767 0.318 . . . . 0.0 110.63 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -71.76 -28.67 63.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 4.9 tp -72.39 -39.23 68.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.005 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.63 -49.56 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.94 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.45 71.02 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 10.8 t80 -86.37 -33.02 20.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.2 m-85 -76.56 -31.54 57.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.96 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -81.4 -29.59 33.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.55 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.21 -34.77 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.297 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 56' ' ' PRO . 93.7 t -70.54 -31.68 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.757 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' A' ' 56' ' ' PRO . . . -94.16 14.92 64.32 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.569 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -118.23 -17.04 9.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.581 0.229 . . . . 0.0 111.595 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 74.9 mmm -140.6 34.06 1.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.544 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -145.3 -64.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.6 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 21.3 Cg_exo -60.93 -17.82 53.53 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.496 1.464 . . . . 0.0 110.401 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.641 HG12 ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.09 -52.92 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.208 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.641 ' N ' HG12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -93.15 -44.31 8.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.496 0.665 . . . . 0.0 110.93 178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -32.3 71.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.779 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -113.13 -6.33 13.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.48 178.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.6 mp0 53.47 24.66 4.15 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.978 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.67 136.74 29.56 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.248 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' C ' ' HD2' ' A' ' 65' ' ' PRO . 58.1 Cg_endo -74.26 -88.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.473 2.115 . . . . 0.0 113.131 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -89.6 -14.23 0.2 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.736 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 95.1 Cg_exo -43.76 -28.43 1.96 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.148 1.899 . . . . 0.0 112.714 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -120.44 130.31 54.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.737 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.07 -160.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.967 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 48' ' ' PHE . 69.3 p -79.83 -78.59 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.636 0.255 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' N ' ' OG1' ' A' ' 68' ' ' THR . . . 55.12 26.63 43.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.561 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.794 0.33 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.87 160.14 39.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.73 173.65 11.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.57 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 5' ' ' THR . 10.0 ptmm? -62.82 129.27 39.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.33 . . . . 0.0 110.609 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.434 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER 159.78 -53.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -92.0 -178.69 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 9' ' ' ASP . 8.1 p90 -129.61 31.39 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 44.37 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.651 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' PHE . 36.5 t70 -115.53 -75.84 0.58 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.722 0.296 . . . . 0.0 110.994 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -59.61 141.37 55.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.774 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -121.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.348 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.57 -41.0 40.47 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -87.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.189 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER 44.43 85.07 0.18 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.344 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.59 -25.77 76.1 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.696 2.264 . . . . 0.0 112.448 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 11.4 tptp -90.34 -16.85 28.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.121 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.763 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 4.7 m -91.92 -55.7 3.36 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.58 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' CG ' ' H ' ' A' ' 19' ' ' LEU . 5.7 p30 -52.95 -66.57 0.36 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' CG ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -75.78 -42.59 49.77 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.0 111.15 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.638 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -71.82 -31.72 66.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.748 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.763 ' HB3' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.55 -22.49 43.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.419 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.479 ' N ' HD12 ' A' ' 21' ' ' LEU . 40.5 t90 -82.21 -48.36 11.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 20' ' ' ARG . 12.0 p -65.31 -30.67 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.333 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 20' ' ' ARG . . . -83.5 -26.8 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -58.23 -38.88 77.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.712 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.13 -30.57 16.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.476 0.655 . . . . 0.0 110.519 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.73 -34.96 76.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.823 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -34.88 13.17 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.59 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 7.5 ttpp -98.22 -33.89 10.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -84.24 -9.27 82.34 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -90.38 -53.61 4.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.67 0.271 . . . . 0.0 111.612 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.23 -40.16 34.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.8 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -79.33 -69.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.63 0.253 . . . . 0.0 111.322 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -61.78 -57.98 9.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.253 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -29.53 -46.4 0.09 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.727 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.01 10.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.503 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 t -75.25 -55.41 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.273 0.559 . . . . 0.0 110.922 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.411 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -64.73 -58.29 6.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.201 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 3.1 t80 -59.84 -43.25 94.71 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.039 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.537 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -52.73 -32.19 39.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.197 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.4 m -82.39 -52.19 7.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.844 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 46' ' ' GLY . 58.2 mt -57.45 -36.59 71.61 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.444 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -72.19 -30.74 65.25 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 3.1 tp -73.06 -50.06 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 mt -82.92 -46.35 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.012 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -64.41 -34.32 89.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 21.7 t80 -76.69 -33.17 58.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.207 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -75.46 -32.9 60.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.531 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -29.46 66.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 46' ' ' GLY . 14.0 t -78.33 -30.63 15.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.358 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG11 ' N ' ' A' ' 52' ' ' GLY . 2.4 p -62.46 -27.91 43.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.795 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' N ' HG11 ' A' ' 51' ' ' VAL . . . -99.06 -5.43 56.29 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.621 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -137.14 50.13 2.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.741 0.305 . . . . 0.0 111.271 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.438 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 169.82 28.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.87 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.554 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.65 -65.4 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 37.7 Cg_exo -57.41 -17.37 26.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.312 1.342 . . . . 0.0 110.255 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.586 HD13 ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -81.87 -52.3 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.563 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.586 ' HB3' HD13 ' A' ' 57' ' ' ILE . 5.5 pt20 -90.34 -18.17 26.03 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.5 tt0 -63.08 -24.03 67.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.62 -9.69 59.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.491 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 65.34 17.76 11.1 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.042 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' CB ' ' HG2' ' A' ' 65' ' ' PRO . . . -153.21 165.3 17.97 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' C ' ' HD2' ' A' ' 65' ' ' PRO . 56.8 Cg_endo -70.08 -94.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.295 1.997 . . . . 0.0 112.801 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.73 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -83.68 -22.89 0.32 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 75.1 Cg_exo -46.24 153.85 0.97 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.266 1.977 . . . . 0.0 112.606 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -169.82 -61.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 mt 67.37 -71.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 t -160.01 -161.36 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.796 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.58 138.42 10.63 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.743 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.195 -179.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.847 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.67 120.89 24.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -175.53 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -169.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -91.29 74.37 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.4 mp -100.36 -59.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 8' ' ' ASN . 17.7 t80 -167.71 138.1 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.21 135.78 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.42 -29.87 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -59.62 -25.29 64.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.19 -2.89 33.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.619 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 72.23 -152.02 0.08 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.426 0.155 . . . . 0.0 110.684 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -41.27 149.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 111.57 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 4.6 t-20 -77.13 -46.98 2.71 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 60.5 Cg_exo -51.03 -25.22 15.82 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.187 1.924 . . . . 0.0 112.431 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.4 tmpt? -56.49 -32.82 65.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 21' ' ' LEU . 82.5 m -90.52 -55.18 3.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.015 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 8.8 m-80 -56.26 -35.01 66.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.458 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 ' C ' ' N ' ' A' ' 21' ' ' LEU . 2.9 tt -75.85 -52.85 9.47 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.292 0.568 . . . . 0.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -53.48 -16.18 1.37 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.817 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.15 -62.86 1.51 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.155 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -64.47 -43.27 94.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.837 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 27' ' ' MET . 22.0 t -56.58 -35.58 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.731 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 28' ' ' MET . . . -79.68 -26.74 40.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.6 -37.47 78.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.61 -41.78 10.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 111.63 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -69.21 -39.57 78.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.39 -179.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -92.68 -41.83 9.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.751 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 23.8 mtmt -97.08 -29.72 13.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.484 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -87.7 -5.2 78.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -86.46 -60.02 2.11 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.777 0.322 . . . . 0.0 111.706 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.29 -20.85 79.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.049 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -78.5 -70.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.714 0.292 . . . . 0.0 111.242 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -57.09 -59.94 4.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.28 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -27.75 -48.28 0.06 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.975 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.52 -39.96 10.35 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.511 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -75.28 -55.27 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.159 0.504 . . . . 0.0 111.041 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -65.3 -56.05 14.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.167 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 4.5 t80 -61.4 -41.94 97.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.752 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.573 ' O ' HD13 ' A' ' 43' ' ' LEU . . . -54.4 -31.73 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.396 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 m -84.39 -47.06 11.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.53 0.205 . . . . 0.0 110.622 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.8 mt -58.87 -34.97 72.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.625 HD12 HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.22 -33.05 67.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.683 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -73.0 -44.06 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.462 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.22 -42.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -67.29 -30.47 75.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -83.45 -33.1 25.73 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 109.894 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -77.1 -31.47 55.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.905 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -29.77 56.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.56 -30.86 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' HD3' ' A' ' 56' ' ' PRO . 64.9 t -63.45 -18.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.751 -0.38 . . . . 0.0 109.992 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.33 -11.35 29.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.363 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -115.89 30.27 7.45 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.104 0.452 . . . . 0.0 111.258 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.402 ' HA ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -179.56 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.534 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.568 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -147.38 -61.91 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 17.5 Cg_exo -64.11 -17.69 60.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.794 1.663 . . . . 0.0 110.005 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -80.4 -41.41 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.635 ' HB3' HD12 ' A' ' 57' ' ' ILE . 16.1 pt20 -90.19 -15.97 30.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -58.7 -24.49 61.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.338 0.589 . . . . 0.0 109.456 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -22.78 66.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.998 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 61.94 28.6 17.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.062 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.89 122.18 27.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.085 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.13 -93.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.23 1.954 . . . . 0.0 112.383 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.649 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -59.67 -46.44 98.56 Favored Pre-proline 0 CA--C 1.53 0.193 0 O-C-N 122.471 -0.143 . . . . 0.0 111.229 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 64' ' ' ALA . 81.6 Cg_exo -33.32 -60.99 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.215 2.61 . . . . 0.0 113.424 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -168.08 86.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tp -78.27 -30.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.0 t -124.63 -45.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.32 -129.1 19.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.051 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.754 0.311 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.92 159.19 17.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 -167.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.66 137.69 32.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.86 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.14 32.72 21.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.774 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.2 tt -155.65 52.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 111.181 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.92 37.07 1.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.679 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -108.99 33.16 4.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -94.82 -53.48 3.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -89.81 -60.23 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -151.59 -179.18 7.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -63.43 -68.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.766 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -57.66 168.63 0.83 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -172.58 67.05 0.38 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.56 -25.22 48.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.494 2.129 . . . . 0.0 111.912 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.77 -27.23 64.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.038 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.514 ' O ' HD22 ' A' ' 21' ' ' LEU . 30.2 m -74.61 -21.04 59.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.187 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.44 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 37.9 m-20 -97.96 -42.43 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.865 0.364 . . . . 0.0 111.947 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.5 tp -75.16 -32.73 61.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.503 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -64.96 -33.61 76.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -83.46 -30.78 26.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.265 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.94 -44.71 76.2 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 27' ' ' MET . 52.6 t -64.48 -33.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.195 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.62 -26.78 41.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -43.44 89.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.67 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -89.68 -28.47 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.431 0.634 . . . . 0.0 110.14 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.647 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.42 -31.89 71.55 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.528 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 ttp -92.55 -33.4 14.46 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.097 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.95 -18.99 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 110.19 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -103.33 -9.67 38.19 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.943 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.647 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -96.11 -45.56 6.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 0.0 111.651 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.73 -47.83 9.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -63.65 -56.69 13.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.263 . . . . 0.0 111.338 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -53.1 -61.85 2.03 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.409 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -22.7 -53.78 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.972 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -44.16 9.52 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -75.31 -55.3 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.222 0.534 . . . . 0.0 111.062 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -59.51 -58.63 7.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.054 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 2.7 t80 -53.6 -43.72 68.85 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.258 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.533 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -54.55 -31.26 52.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.603 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -85.64 -45.05 12.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.823 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 38' ' ' PHE . 9.7 mt -60.9 -35.9 77.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 110.523 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -72.56 -31.88 65.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 1.3 tp -72.45 -45.23 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.507 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.9 mt -85.7 -41.8 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -68.62 -31.15 73.15 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.646 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 42.0 t80 -79.95 -32.44 39.98 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.91 0.386 . . . . 0.0 110.467 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.37 -51.98 10.82 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -29.72 68.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -80.16 -33.79 14.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.173 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -21.85 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.408 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.54 -9.26 31.39 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.247 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.4 41.55 3.49 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.974 0.387 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.45 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 170.53 31.45 0.0 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.619 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.96 -65.49 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 38.9 Cg_exo -55.69 -17.58 18.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.29 1.327 . . . . 0.0 110.235 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -81.26 -55.26 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.57 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.516 ' HB3' HD13 ' A' ' 57' ' ' ILE . 10.1 pt20 -91.01 -18.16 25.08 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.4 tp10 -60.58 -22.46 63.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.35 -27.95 69.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.884 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 55.96 32.96 20.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.259 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.91 121.98 3.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 56.8 Cg_endo -81.54 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.319 2.013 . . . . 0.0 113.061 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.707 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -68.02 -29.3 2.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 38.5 Cg_exo -56.89 -147.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.614 2.209 . . . . 0.0 112.172 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 4.3 m-80 74.01 -67.71 0.25 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -156.86 -179.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.444 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.8 p -79.89 137.6 36.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.38 138.92 3.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.449 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.095 179.949 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.42 142.35 33.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.55 -76.38 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -89.96 -177.9 5.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 t -86.61 55.86 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.973 0.416 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.34 9.4 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.44 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 57.6 57.61 4.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.52 -164.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -49.58 -53.39 24.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -61.42 118.08 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -125.02 -164.31 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.788 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.51 -64.32 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 t -88.76 86.5 6.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -133.75 66.65 73.57 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.68 -25.05 57.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 112.514 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -74.67 -33.8 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 111.039 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.603 ' O ' ' CD1' ' A' ' 21' ' ' LEU . 84.9 m -90.18 -21.91 21.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.32 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.56 -66.98 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.884 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.72 -52.88 8.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.89 -31.94 73.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.603 ' CD1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.21 -26.19 42.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.692 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -82.28 -37.7 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 27' ' ' MET . 84.5 t -63.5 -37.14 78.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.611 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.61 -26.79 41.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.801 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -63.28 -35.67 81.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.209 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.59 -40.28 11.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.222 0.534 . . . . 0.0 111.108 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.595 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.2 -43.22 67.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.339 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.6 ttp -92.35 -41.73 10.19 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.551 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.801 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 1.7 ttpt -96.07 -32.38 12.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -85.01 -4.13 87.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.38 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -88.2 -59.6 2.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.37 62.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.012 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -82.34 -69.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.362 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 38' ' ' PHE . . . -47.69 -28.64 2.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.68 -57.54 13.84 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.023 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.76 -31.18 24.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t -75.35 -55.11 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 110.722 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -71.65 -58.16 3.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.853 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.567 ' O ' HD22 ' A' ' 43' ' ' LEU . . . -58.63 -31.18 66.7 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.14 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 m -82.5 -46.21 13.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 0.0 110.415 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLY . 5.2 mt -60.4 -38.09 82.89 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.612 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -71.92 -28.9 63.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.6 tp -72.85 -44.79 60.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.945 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 mt -87.85 -49.5 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.29 -24.33 65.36 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.565 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 6.5 t80 -88.86 -33.05 17.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.975 0.417 . . . . 0.0 110.106 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -32.86 64.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -79.61 -34.12 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.713 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m -80.39 -30.69 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.376 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' HD3' ' A' ' 56' ' ' PRO . 78.7 t -74.94 -29.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 13.6 65.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.507 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 29.5 tpt85 -122.23 -15.26 7.74 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.436 ' HA ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.45 45.57 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -153.89 -66.84 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 55' ' ' LEU . 36.5 Cg_exo -52.53 -17.84 7.39 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.663 1.575 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.734 HG12 ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -67.46 -57.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.685 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.734 ' N ' HG12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -92.91 -37.38 12.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.9 -28.45 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.932 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -113.69 -16.57 12.29 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.296 178.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER 54.1 23.01 3.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.807 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . . . -153.01 167.98 12.35 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.584 ' C ' ' HD2' ' A' ' 65' ' ' PRO . 19.2 Cg_endo -58.75 -160.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.467 2.111 . . . . 0.0 112.351 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.647 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -66.68 -27.17 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 84.2 Cg_exo -46.35 99.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.423 2.082 . . . . 0.0 112.696 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -173.51 174.12 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.58 137.47 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.46 169.16 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.799 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.78 76.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.777 0.323 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.34 150.37 49.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 75.03 -62.47 0.45 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -80.79 141.89 34.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.671 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p 70.21 10.66 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.472 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 tt -162.6 147.41 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.752 0.31 . . . . 0.0 111.154 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -57.91 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.52 150.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.878 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.25 169.19 5.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -68.4 71.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.96 69.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 62.1 110.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 72.59 178.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 2.2 t-20 173.1 -47.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.765 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 39.4 Cg_exo -60.94 -10.04 13.67 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.418 2.079 . . . . 0.0 112.56 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -49.21 -27.09 3.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.545 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 31.6 m -91.64 -22.71 20.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 4.8 m-80 -101.57 -57.8 2.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.29 62.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.304 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -64.04 -38.96 92.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.02 -23.1 44.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.738 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.471 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -76.96 -55.23 5.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -57.45 -29.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.34 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' HA ' ' CG ' ' A' ' 27' ' ' MET . . . -78.35 -26.08 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.097 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -71.37 -30.27 65.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.099 -179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.87 -37.48 12.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 112.037 -179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.614 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -65.32 -37.19 86.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.298 0.571 . . . . 0.0 111.163 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.7 ttp -92.71 -41.59 10.07 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.113 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 3.2 mtmm -95.4 -43.99 7.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.115 0.483 . . . . 0.0 110.096 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -70.63 -13.14 71.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.114 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -77.8 -45.76 23.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.766 0.317 . . . . 0.0 111.547 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.77 -35.05 66.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.709 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -71.47 -71.97 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.604 0.24 . . . . 0.0 111.32 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -45.82 -58.76 3.24 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.439 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -23.74 -50.64 0.02 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.565 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -78.82 -47.99 7.41 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.389 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 t -75.15 -55.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.378 0.609 . . . . 0.0 110.991 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -55.64 -58.08 9.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.022 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 1.1 t80 -53.95 -43.16 69.63 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.172 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.557 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -54.75 -31.25 53.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.347 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.1 m -84.61 -48.28 9.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.684 0.278 . . . . 0.0 110.703 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 46' ' ' GLY . 22.2 mt -58.66 -36.64 74.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.14 -31.9 66.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -72.63 -45.87 56.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.87 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 mt -87.73 -48.57 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.67 -28.79 72.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -84.86 -33.26 22.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -73.05 -35.9 66.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -75.72 -32.85 60.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.408 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 47' ' ' PHE . 9.8 p -80.74 -30.13 11.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.469 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' HD3' ' A' ' 56' ' ' PRO . 66.0 t -68.38 -9.73 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.94 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.77 -14.53 9.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.444 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 54' ' ' MET . 3.6 ttt85 -105.55 3.84 29.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.144 0.472 . . . . 0.0 111.757 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 53' ' ' ARG . 3.6 mmt -163.57 47.66 0.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.802 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -151.77 -61.82 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 35.9 Cg_exo -58.6 -17.6 35.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 121.629 1.553 . . . . 0.0 110.351 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -80.68 -50.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.137 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.488 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.8 -14.52 31.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.423 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -61.73 -20.84 63.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.012 0.434 . . . . 0.0 109.902 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -24.9 30.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.393 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 24.95 8.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.209 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.15 136.64 79.09 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.96 -97.58 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.178 1.919 . . . . 0.0 112.173 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.677 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -61.87 -46.12 92.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.388 0.137 . . . . 0.0 111.25 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 64' ' ' ALA . 76.2 Cg_exo -34.72 -34.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.248 2.632 . . . . 0.0 113.305 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -112.08 123.29 49.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.873 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.1 pt -61.49 144.94 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.4 m -87.76 125.82 34.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.03 -40.73 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.493 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.094 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.79 118.89 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -179.23 -78.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 170.06 10.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.756 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 p -75.85 63.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.0 mp 60.81 158.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.06 -167.39 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 62.54 96.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -137.02 -160.78 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.743 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -44.9 -38.74 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.824 0.345 . . . . 0.0 111.474 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.13 160.49 38.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -81.47 60.83 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -100.99 78.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -132.42 67.54 78.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.75 -25.38 60.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.104 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -27.85 64.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 ' O ' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -90.41 -55.24 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.684 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 9.2 m-80 -43.5 -43.96 5.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.048 0.451 . . . . 0.0 111.39 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.6 tp -74.04 -31.18 62.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.824 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -61.87 -39.49 92.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.44 -30.83 42.41 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.092 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.435 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 5.9 t90 -71.1 -41.13 70.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 27' ' ' MET . 70.4 t -67.64 -31.58 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.147 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.7 -26.67 40.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.627 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -70.64 -31.72 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.722 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -92.06 -29.15 16.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.763 0.792 . . . . 0.0 109.798 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.573 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.03 -34.0 74.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.805 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.7 ttp -94.19 -40.18 10.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.148 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -95.08 -39.25 10.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.492 0.663 . . . . 0.0 110.625 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -79.34 -13.31 82.89 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.598 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -77.44 -55.66 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.32 -46.61 19.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.661 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -76.17 -69.83 0.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.575 0.226 . . . . 0.0 111.378 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -56.73 -54.06 50.58 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.056 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -27.86 -46.97 0.05 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.469 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -79.4 -46.85 7.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.917 -0.658 . . . . 0.0 113.357 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.2 t -75.18 -55.31 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.442 0.639 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -59.77 -58.0 10.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.399 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 1.9 t80 -56.68 -41.62 77.63 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -55.47 -34.04 59.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.626 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 m -83.08 -44.67 14.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.683 0.278 . . . . 0.0 110.635 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 4.8 mt -60.82 -35.5 76.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.861 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.714 ' O ' ' CB ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -72.59 -30.32 64.28 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 6.3 tp -72.93 -50.18 25.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.028 0.442 . . . . 0.0 110.927 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -81.48 -47.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.587 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.36 -23.56 64.64 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.714 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 64.6 t80 -81.54 -33.7 31.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -32.55 39.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -32.43 62.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.469 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 35.1 m -81.4 -27.64 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.192 0.52 . . . . 0.0 111.743 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.457 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 67.0 t -80.77 -5.56 8.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.06 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.82 18.75 4.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 27.6 ttt-85 -155.58 -46.0 0.08 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.282 0.563 . . . . 0.0 110.883 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.402 ' HA ' HD11 ' A' ' 57' ' ' ILE . 35.9 mtp -109.97 59.27 0.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.97 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.488 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -155.27 -59.07 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 22.1 Cg_exo -62.84 -17.48 59.72 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.793 1.662 . . . . 0.0 110.226 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -84.42 -38.09 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.585 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.547 ' HB3' HD12 ' A' ' 57' ' ' ILE . 5.8 pt20 -90.07 -16.41 29.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.17 -24.05 66.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.354 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -67.86 -29.04 68.07 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.207 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.46 14.26 9.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.667 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.04 31.46 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.819 0.343 . . . . 0.0 111.336 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.551 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 27.5 Cg_endo -62.83 -162.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.418 2.079 . . . . 0.0 112.181 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.703 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -70.86 -22.51 0.6 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.703 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 23.1 Cg_exo -62.45 3.93 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.725 2.283 . . . . 0.0 113.491 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 64' ' ' ALA . 1.1 t-20 -70.75 66.0 0.34 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.925 0.393 . . . . 0.0 110.51 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.08 163.68 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.183 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -107.67 -31.04 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.93 177.37 14.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 0.0 111.066 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.29 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.24 -165.22 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -78.86 129.9 35.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t 43.09 68.89 0.44 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.542 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.55 139.14 18.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -84.1 -108.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 48.67 -171.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.824 0.345 . . . . 0.0 111.104 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.06 -72.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -60.68 -176.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -168.12 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -69.51 85.3 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 p -147.07 -148.17 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.727 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.24 -52.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 CA-C-O 120.463 0.173 . . . . 0.0 111.238 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.33 -24.15 8.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.975 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -68.95 -52.88 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 111.148 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.531 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 89.0 m -90.57 -22.09 21.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.85 0.357 . . . . 0.0 111.407 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.42 -61.43 1.7 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.405 ' C ' ' N ' ' A' ' 21' ' ' LEU . 1.5 tp -76.1 -53.03 8.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -52.25 -17.99 1.36 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.816 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 17' ' ' THR . 1.2 mm? -77.94 -63.18 1.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 4.5 t90 -61.11 -44.48 97.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.845 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 27' ' ' MET . 26.3 t -51.37 -31.84 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.37 41.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.847 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.822 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.04 -29.35 70.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.551 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.15 -37.09 13.59 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.891 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.97 -36.66 23.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.261 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.4 ttp -91.9 -43.61 9.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.828 0.347 . . . . 0.0 111.205 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.3 mtmt -93.8 -31.18 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' O ' ' HB1' ' A' ' 34' ' ' ALA . . . -88.13 0.59 84.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.41 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -88.93 -59.43 2.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.69 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.81 -36.21 42.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.129 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.423 ' CD1' HG23 ' A' ' 37' ' ' VAL . 48.6 t90 -73.42 -68.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -44.26 -73.27 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -18.03 -60.64 0.01 OUTLIER Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.031 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 -40.64 11.54 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.943 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 33' ' ' TRP . 60.4 t -75.3 -55.41 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.16 0.505 . . . . 0.0 111.178 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -60.08 -58.39 8.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.079 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -69.65 -41.66 75.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.699 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' O ' HD21 ' A' ' 43' ' ' LEU . . . -57.54 -31.48 63.46 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.21 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 84.9 m -84.34 -46.25 11.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.243 . . . . 0.0 110.657 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 38' ' ' PHE . 3.1 mt -60.57 -38.58 85.05 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -71.94 -29.14 63.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 2.5 tp -72.95 -48.23 38.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.907 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.32 -48.17 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.329 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -62.26 -33.6 86.55 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.301 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.15 -32.82 44.43 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -40.03 49.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -28.88 67.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 46' ' ' GLY . 93.0 t -69.13 -46.4 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 25.3 t -56.69 -30.26 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.222 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA2' ' HG2' ' A' ' 56' ' ' PRO . . . -87.94 3.78 85.79 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.453 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.19 4.42 15.53 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.413 ' HG3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -156.18 30.62 0.34 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -147.76 -64.16 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 25.7 Cg_exo -57.65 -17.29 28.09 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.13 1.22 . . . . 0.0 109.763 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -86.37 -55.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.386 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.483 ' HB3' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -91.28 -34.13 15.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' LEU . 21.7 tp10 -65.31 -31.06 71.99 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.113 0.483 . . . . 0.0 109.975 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -86.23 -24.15 26.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.363 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 51.16 26.25 2.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.86 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.21 173.2 4.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.64 -88.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.803 2.335 . . . . 0.0 113.073 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -60.74 -61.66 7.53 Favored Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 64' ' ' ALA . 4.8 Cg_exo -38.66 93.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.388 2.726 . . . . 0.0 112.965 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -139.95 -170.24 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.25 54.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 t -136.06 143.49 44.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.88 -79.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.5 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.827 0.346 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.94 157.25 45.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -140.88 178.39 7.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 m 69.86 -72.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.5 pt 40.81 57.42 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.645 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.55 157.07 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -166.56 179.21 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.771 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.91 -162.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.674 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -50.97 95.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.078 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.8 165.26 16.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.852 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.58 -59.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -177.77 101.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.981 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -108.04 145.1 30.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.35 -34.69 81.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.556 2.171 . . . . 0.0 112.599 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.57 -58.6 5.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.436 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.1 m -67.95 -30.21 69.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.839 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.6 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 1.1 m120 -51.21 -66.48 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.005 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -76.17 -43.02 44.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.86 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 4.4 tpm_? -52.48 -29.97 27.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.673 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 18' ' ' ASN . 4.2 pp -78.7 -41.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.887 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 24.5 t90 -61.96 -45.31 94.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.665 ' O ' ' HB3' ' A' ' 27' ' ' MET . 13.0 t -60.28 -30.18 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.342 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.21 -26.79 42.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.938 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -45.61 92.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.893 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.54 -28.57 18.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 179.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.665 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.99 -31.61 70.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.838 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -38.78 11.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.563 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -50.79 5.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 109.53 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -63.43 -20.68 63.7 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.492 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -80.03 -57.18 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.61 -67.74 1.79 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.973 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -48.47 -64.22 0.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -51.43 -61.65 2.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.348 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -23.36 -52.83 0.03 OUTLIER Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.891 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -79.45 -44.45 9.49 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.678 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 34' ' ' ALA . 22.0 t -74.68 -55.44 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.24 0.543 . . . . 0.0 111.209 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -61.96 -59.28 5.33 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.885 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.648 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 8.4 t80 -49.55 -39.64 35.46 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 122.252 -0.28 . . . . 0.0 111.191 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -52.04 -44.87 56.89 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.103 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.7 m -82.35 -53.35 6.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.181 0.515 . . . . 0.0 110.734 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -49.98 -45.58 51.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.344 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.648 ' HB3' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -72.11 -30.41 65.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.718 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.443 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 3.6 tp -73.06 -47.45 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.044 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mt -80.51 -46.58 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.539 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -66.13 -43.22 93.68 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 14.0 t80 -66.66 -32.85 74.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.094 0.474 . . . . 0.0 109.86 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 4.4 m-30 -75.35 -30.3 60.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.947 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.07 -28.97 57.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 46' ' ' GLY . 2.5 t -80.25 -29.86 12.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.58 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.5 -12.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.864 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.42 4.36 13.5 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.24 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 ttt-85 -158.74 41.49 0.24 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.961 0.381 . . . . 0.0 111.732 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.464 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 167.8 48.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.919 -179.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.509 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -154.63 -60.54 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 23.4 Cg_exo -61.95 -17.83 57.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.744 1.629 . . . . 0.0 110.302 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -80.42 -38.86 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.315 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.497 ' HB3' HD13 ' A' ' 57' ' ' ILE . 7.0 pt20 -90.27 -12.27 38.38 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.979 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -25.74 59.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.77 -20.75 62.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.239 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 73.05 31.51 1.47 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 65' ' ' PRO . . . -153.13 132.28 6.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.26 -77.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.373 2.049 . . . . 0.0 112.277 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.74 ' N ' ' HD3' ' A' ' 65' ' ' PRO . . . -145.72 45.13 0.46 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.74 ' HD3' ' N ' ' A' ' 64' ' ' ALA . 4.5 Cg_endo -87.77 -16.86 2.83 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.915 2.41 . . . . 0.0 112.031 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.94 129.28 48.17 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.238 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -103.19 145.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.9 -84.89 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.703 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.26 98.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.623 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.777 0.322 . . . . 0.0 111.018 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.838 0.351 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.12 175.02 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.92 -178.23 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 173.04 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.84 -65.66 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -70.72 152.92 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -53.79 149.05 9.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -70.5 -46.71 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 68.5 72.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -48.42 77.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.11 -60.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.64 37.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.616 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.05 95.81 5.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 3.7 t30 -79.65 -34.89 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.964 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 14' ' ' ASN . 88.7 Cg_exo -48.4 -23.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.302 2.001 . . . . 0.0 112.816 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.95 -27.41 7.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 110.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' HD22 ' A' ' 21' ' ' LEU . 78.8 m -90.38 -55.48 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.812 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 23.2 m-20 -46.89 -35.47 6.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.121 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' A' ' 21' ' ' LEU . 1.2 tp -75.61 -52.36 10.75 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.427 0.632 . . . . 0.0 110.083 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -52.36 -16.76 0.93 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.746 178.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -77.58 -63.07 1.46 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.793 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.26 -34.29 77.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.821 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.633 ' O ' ' HB3' ' A' ' 27' ' ' MET . 40.3 t -65.5 -34.14 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.658 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.58 -26.9 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -42.3 99.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.959 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 pt20 -91.07 -28.9 17.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.088 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.633 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.967 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.5 ttm -93.45 -41.66 9.68 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.09 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.62 -39.75 10.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.413 0.625 . . . . 0.0 110.41 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -80.72 -8.2 87.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.846 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -82.37 -60.14 2.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.57 -33.82 33.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.948 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -65.95 0.97 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 38' ' ' PHE . . . -65.72 -34.11 77.44 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 111.009 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . -50.56 -60.35 6.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.314 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 -40.14 14.06 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.38 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.55 -55.37 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.144 0.497 . . . . 0.0 111.456 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -66.19 -59.46 3.74 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.522 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.695 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 23.4 t80 -44.7 -45.2 9.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.065 0.393 . . . . 0.0 111.414 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' O ' HD21 ' A' ' 43' ' ' LEU . . . -49.52 -48.6 34.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.448 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.8 m -81.61 -53.77 5.97 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.061 0.458 . . . . 0.0 111.218 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -50.31 -44.07 54.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.603 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -71.93 -31.51 66.42 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 2.6 tp -73.21 -49.99 24.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.389 0.614 . . . . 0.0 110.691 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.2 mt -81.01 -52.14 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.141 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -60.58 -28.88 68.42 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.607 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 28.5 t80 -79.66 -32.98 41.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.061 0.458 . . . . 0.0 110.014 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -31.92 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -29.87 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.648 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m -81.12 -28.55 10.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.509 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 65.0 t -74.66 -12.23 14.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.529 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.82 21.19 4.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.021 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -172.98 28.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.696 0.284 . . . . 0.0 111.542 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 179.82 40.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.134 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.577 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -147.48 -64.72 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 27.7 Cg_exo -57.45 -17.55 27.87 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.266 1.311 . . . . 0.0 109.849 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.65 -35.93 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.948 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.532 ' N ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -90.39 -16.64 28.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.638 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -68.39 -18.32 64.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.81 23.85 6.68 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.413 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 70.48 143.8 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.26 157.52 4.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.379 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.78 71.48 2.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.622 2.215 . . . . 0.0 112.082 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -176.63 -62.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.379 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 64' ' ' ALA . 2.5 Cg_endo -45.08 -51.77 7.23 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.847 2.365 . . . . 0.0 112.692 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -108.79 -29.98 8.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.068 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.12 62.98 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.87 -47.39 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.824 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.27 27.42 30.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.547 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 111.031 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.2 tt -75.56 -37.63 59.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -39.74 94.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.35 -18.14 53.05 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.848 ' N ' HD13 ' A' ' 21' ' ' LEU . 5.6 t90 -84.43 -42.91 15.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 19' ' ' LEU . 69.1 t -63.22 -32.7 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.213 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.63 -26.67 41.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.755 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -61.41 -42.77 99.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.1 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' GLY . 2.3 pt20 -90.61 -29.7 17.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.68 0.752 . . . . 0.0 109.714 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.637 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.92 -31.85 69.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.181 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.1 ttp -93.01 -41.2 10.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.087 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HE2' ' CD1' ' A' ' 25' ' ' PHE . 9.5 mtpt -91.4 -58.16 2.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -51.76 -27.2 19.27 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.859 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.699 0.285 . . . . 0.0 111.314 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.8 m -84.54 -47.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.66 -40.77 84.44 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.767 0.318 . . . . 0.0 110.63 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.76 -28.67 63.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.9 tp -72.39 -39.23 68.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.005 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.63 -49.56 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.94 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.668 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -63.64 -27.45 71.02 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 10.8 t80 -86.37 -33.02 20.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.2 m-85 -76.56 -31.54 57.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.96 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -81.4 -29.59 33.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.55 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' GLY . 28.3 m . . . . . 0 CA--C 1.518 -0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.297 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.76 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -75.78 -42.59 49.77 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.0 111.15 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.657 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -71.82 -31.72 66.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.748 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.902 HD13 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.55 -22.49 43.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.419 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.902 ' N ' HD13 ' A' ' 21' ' ' LEU . 40.5 t90 -82.21 -48.36 11.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 19' ' ' LEU . 12.0 p -65.31 -30.67 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.333 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -83.5 -26.8 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -58.23 -38.88 77.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.712 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.2 pt20 -91.13 -30.57 16.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.476 0.655 . . . . 0.0 110.519 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.73 -34.96 76.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.823 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -34.88 13.17 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.59 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 7.5 ttpp -98.22 -33.89 10.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -84.24 -9.27 82.34 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.67 0.271 . . . . 0.0 111.612 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.4 m -82.39 -52.19 7.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.844 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 58.2 mt -57.45 -36.59 71.61 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.444 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.19 -30.74 65.25 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.908 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.1 tp -73.06 -50.06 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 mt -82.92 -46.35 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.012 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.929 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -64.41 -34.32 89.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 21.7 t80 -76.69 -33.17 58.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.207 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -75.46 -32.9 60.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.531 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -29.46 66.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.929 HG23 ' O ' ' A' ' 46' ' ' GLY . 14.0 t . . . . . 0 C--O 1.221 -0.413 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 8.8 m-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.9 tt -75.85 -52.85 9.47 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.292 0.568 . . . . 0.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -53.48 -16.18 1.37 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.817 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -77.15 -62.86 1.51 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.155 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -64.47 -43.27 94.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.837 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 19' ' ' LEU . 22.0 t -56.58 -35.58 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.731 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 28' ' ' MET . . . -79.68 -26.74 40.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.6 -37.47 78.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 1.8 pt20 -91.61 -41.78 10.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 111.63 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -69.21 -39.57 78.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.39 -179.106 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -92.68 -41.83 9.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.751 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 23.8 mtmt -97.08 -29.72 13.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.484 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -87.7 -5.2 78.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.777 0.322 . . . . 0.0 111.706 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.475 HG22 HD12 ' A' ' 45' ' ' ILE . 5.0 m -84.39 -47.06 11.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.53 0.205 . . . . 0.0 110.622 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 42' ' ' LEU . 1.8 mt -58.87 -34.97 72.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.22 -33.05 67.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -73.0 -44.06 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.462 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 41' ' ' THR . 12.4 mt -89.22 -42.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -67.29 -30.47 75.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -83.45 -33.1 25.73 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 109.894 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.712 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -77.1 -31.47 55.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.905 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -76.63 -29.77 56.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.917 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.715 ' HA ' HD21 ' A' ' 21' ' ' LEU . 37.9 m-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.947 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -75.16 -32.73 61.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.503 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.636 ' NH2' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -64.96 -33.61 76.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.837 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -83.46 -30.78 26.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.265 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.94 -44.71 76.2 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 19' ' ' LEU . 52.6 t -64.48 -33.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.195 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -79.62 -26.78 41.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -43.44 89.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.67 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -89.68 -28.47 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.431 0.634 . . . . 0.0 110.14 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -68.42 -31.89 71.55 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.528 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 ttp -92.55 -33.4 14.46 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.097 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.95 -18.99 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 110.19 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -103.33 -9.67 38.19 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.943 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.647 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 0.0 111.651 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 45' ' ' ILE . 12.9 m -85.64 -45.05 12.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.823 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.9 -35.9 77.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 110.523 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.56 -31.88 65.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.989 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 tp -72.45 -45.23 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.507 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 41' ' ' THR . 8.9 mt -85.7 -41.8 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -68.62 -31.15 73.15 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.646 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 42.0 t80 -79.95 -32.44 39.98 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.91 0.386 . . . . 0.0 110.467 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.37 -51.98 10.82 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -29.72 68.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.173 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.72 -52.88 8.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.824 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.89 -31.94 73.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.235 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.937 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.21 -26.19 42.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.692 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.894 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.7 t90 -82.28 -37.7 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.5 t -63.5 -37.14 78.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.611 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.61 -26.79 41.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -63.28 -35.67 81.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.209 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.59 -40.28 11.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.222 0.534 . . . . 0.0 111.108 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.2 -43.22 67.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.339 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.6 ttp -92.35 -41.73 10.19 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.551 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.812 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 1.7 ttpt -96.07 -32.38 12.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -85.01 -4.13 87.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.38 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 m -82.5 -46.21 13.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 0.0 110.415 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLY . 5.2 mt -60.4 -38.09 82.89 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.92 -28.9 63.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.898 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.6 tp -72.85 -44.79 60.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.945 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 mt -87.85 -49.5 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.29 -24.33 65.36 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.565 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 6.5 t80 -88.86 -33.05 17.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.975 0.417 . . . . 0.0 110.106 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -32.86 64.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -34.12 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.713 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' GLY . 29.1 m . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.376 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.669 ' O ' HD22 ' A' ' 21' ' ' LEU . 4.8 m-80 . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.25 -31.29 62.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.304 -178.232 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.04 -38.96 92.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.75 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.02 -23.1 44.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.738 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.471 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -76.96 -55.23 5.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 19' ' ' LEU . 44.4 t -57.45 -29.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.34 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' ' CG ' ' A' ' 27' ' ' MET . . . -78.35 -26.08 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.097 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' CA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -71.37 -30.27 65.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.099 -179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.87 -37.48 12.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 112.037 -179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.763 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -65.32 -37.19 86.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.298 0.571 . . . . 0.0 111.163 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.7 ttp -92.71 -41.59 10.07 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.113 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE2' ' CA ' ' A' ' 25' ' ' PHE . 3.2 mtmm -95.4 -43.99 7.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.115 0.483 . . . . 0.0 110.096 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -70.63 -13.14 71.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.114 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.333 -0.129 0 CA-C-O 120.766 0.317 . . . . 0.0 111.547 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.456 HG22 HD12 ' A' ' 45' ' ' ILE . 11.1 m -84.61 -48.28 9.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.684 0.278 . . . . 0.0 110.703 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 46' ' ' GLY . 22.2 mt -58.66 -36.64 74.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.14 -31.9 66.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.925 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.63 -45.87 56.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.87 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 41' ' ' THR . 15.9 mt -87.73 -48.57 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 50' ' ' VAL . . . -62.67 -28.79 72.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -84.86 -33.26 22.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -73.05 -35.9 66.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -75.72 -32.85 60.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.408 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' GLY . 9.8 p . . . . . 0 C--O 1.222 -0.352 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.469 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.674 ' HA ' HD21 ' A' ' 21' ' ' LEU . 9.2 m-80 . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 tp -74.04 -31.18 62.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.824 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -61.87 -39.49 92.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.44 -30.83 42.41 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.092 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 5.9 t90 -71.1 -41.13 70.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 19' ' ' LEU . 70.4 t -67.64 -31.58 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.147 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.7 -26.67 40.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.627 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -70.64 -31.72 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.722 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -92.06 -29.15 16.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.763 0.792 . . . . 0.0 109.798 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.698 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.03 -34.0 74.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.805 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.7 ttp -94.19 -40.18 10.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.148 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -95.08 -39.25 10.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.492 0.663 . . . . 0.0 110.625 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -79.34 -13.31 82.89 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.598 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.309 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.477 HG22 HD12 ' A' ' 45' ' ' ILE . 10.4 m -83.08 -44.67 14.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.683 0.278 . . . . 0.0 110.635 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 4.8 mt -60.82 -35.5 76.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.861 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.59 -30.32 64.28 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.914 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.3 tp -72.93 -50.18 25.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.028 0.442 . . . . 0.0 110.927 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 41' ' ' THR . 9.5 mt -81.48 -47.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.587 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.36 -23.56 64.64 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.72 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 64.6 t80 -81.54 -33.7 31.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -32.55 39.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.75 -32.43 62.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.469 -179.316 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 46' ' ' GLY . 35.1 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.192 0.52 . . . . 0.0 111.743 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.2 t30 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -76.1 -53.03 8.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.642 HH21 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -52.25 -17.99 1.36 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.816 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' A' ' 19' ' ' LEU . 1.2 mm? -77.94 -63.18 1.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -61.11 -44.48 97.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.845 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 19' ' ' LEU . 26.3 t -51.37 -31.84 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 27' ' ' MET . . . -79.42 -26.37 41.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.847 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.828 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.04 -29.35 70.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.551 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 23' ' ' VAL . 2.9 pm0 -91.15 -37.09 13.59 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.891 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.97 -36.66 23.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.261 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.4 ttp -91.9 -43.61 9.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.828 0.347 . . . . 0.0 111.205 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.828 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.3 mtmt -93.8 -31.18 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.13 0.59 84.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.41 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.69 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 84.9 m -84.34 -46.25 11.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.243 . . . . 0.0 110.657 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 46' ' ' GLY . 3.1 mt -60.57 -38.58 85.05 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.893 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.94 -29.14 63.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.893 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.5 tp -72.95 -48.23 38.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.907 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.32 -48.17 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.329 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.985 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -62.26 -33.6 86.55 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.301 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.15 -32.82 44.43 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -40.03 49.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -28.88 67.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 46' ' ' GLY . 93.0 t . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 1.1 m120 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.975 0.417 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.86 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.3 tt -76.17 -43.02 44.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.86 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -52.48 -29.97 27.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.673 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 22' ' ' TRP . 4.2 pp -78.7 -41.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.887 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.713 ' N ' HD12 ' A' ' 21' ' ' LEU . 24.5 t90 -61.96 -45.31 94.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 19' ' ' LEU . 13.0 t -60.28 -30.18 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.342 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.21 -26.79 42.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.938 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -45.61 92.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.893 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.54 -28.57 18.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 179.505 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.706 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.99 -31.61 70.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.838 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -38.78 11.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.563 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -50.79 5.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 109.53 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -63.43 -20.68 63.7 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.492 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . . . . . . 0 CA--C 1.518 0.265 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.7 m -82.35 -53.35 6.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.181 0.515 . . . . 0.0 110.734 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -49.98 -45.58 51.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.344 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.883 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.11 -30.41 65.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.718 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.883 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.6 tp -73.06 -47.45 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.044 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mt -80.51 -46.58 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.539 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -66.13 -43.22 93.68 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 14.0 t80 -66.66 -32.85 74.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.094 0.474 . . . . 0.0 109.86 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 4.4 m-30 -75.35 -30.3 60.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.947 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.07 -28.97 57.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 46' ' ' GLY . 2.5 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.58 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 23.2 m-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.979 0.419 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 tp -75.61 -52.36 10.75 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.427 0.632 . . . . 0.0 110.083 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -52.36 -16.76 0.93 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.746 178.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -77.58 -63.07 1.46 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.793 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.26 -34.29 77.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.821 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 19' ' ' LEU . 40.3 t -65.5 -34.14 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.658 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.58 -26.9 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -42.3 99.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.959 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 pt20 -91.07 -28.9 17.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.088 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.749 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.967 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.5 ttm -93.45 -41.66 9.68 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.09 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HE3' ' N ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -93.62 -39.75 10.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.413 0.625 . . . . 0.0 110.41 -178.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -80.72 -8.2 87.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.846 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 45' ' ' ILE . 25.8 m -81.61 -53.77 5.97 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.061 0.458 . . . . 0.0 111.218 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.887 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.31 -44.07 54.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.603 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.93 -31.51 66.42 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.896 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.6 tp -73.21 -49.99 24.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.389 0.614 . . . . 0.0 110.691 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 41' ' ' THR . 31.2 mt -81.01 -52.14 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.141 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -60.58 -28.88 68.42 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 28.5 t80 -79.66 -32.98 41.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.061 0.458 . . . . 0.0 110.014 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -31.92 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -29.87 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.648 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 46' ' ' GLY . 33.7 m . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.509 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.894 0.378 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.11 146.73 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' C ' HG23 ' A' ' 6' ' ' ILE . 24.2 p-10 -179.37 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.986 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.55 129.72 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p 44.36 37.79 2.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.841 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.549 HG23 ' C ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -66.8 133.46 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 111.377 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -161.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -149.71 113.99 5.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.875 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.61 -88.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -90.35 -89.34 0.16 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.742 HD22 ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -131.83 5.39 4.25 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.405 ' N ' HD13 ' A' ' 11' ' ' LEU . 14.2 p-10 -105.84 178.58 4.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.801 0.334 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -51.4 -88.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' H ' HG23 ' A' ' 13' ' ' THR . 3.4 p-10 172.41 62.33 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.605 0.241 . . . . 0.0 110.934 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 5.5 Cg_exo -77.31 -16.27 15.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.721 2.28 . . . . 0.0 112.382 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.1 -56.73 3.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.728 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.89 ' O ' HD12 ' A' ' 21' ' ' LEU . 77.9 m -61.79 -27.65 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.839 0.352 . . . . 0.0 110.61 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 40.9 t30 -61.79 -66.58 0.52 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.496 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.2 tt -75.56 -37.63 59.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -64.66 -39.74 94.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.35 -18.14 53.05 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.848 ' N ' HD13 ' A' ' 21' ' ' LEU . 5.6 t90 -84.43 -42.91 15.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 19' ' ' LEU . 69.1 t -63.22 -32.7 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.213 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.63 -26.67 41.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.755 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -61.41 -42.77 99.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.1 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' GLY . 2.3 pt20 -90.61 -29.7 17.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.68 0.752 . . . . 0.0 109.714 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.637 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.92 -31.85 69.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.181 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.1 ttp -93.01 -41.2 10.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.087 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HE2' ' CD1' ' A' ' 25' ' ' PHE . 9.5 mtpt -91.4 -58.16 2.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -51.76 -27.2 19.27 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.859 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -76.38 -26.58 55.78 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.699 0.285 . . . . 0.0 111.314 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.87 -7.37 70.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.973 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.708 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.1 t-105 -83.95 -72.14 0.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.837 0.319 . . . . 0.0 110.981 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.29 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.849 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . -56.76 -49.04 73.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.878 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.528 ' O ' ' HA3' ' A' ' 40' ' ' GLY . . . -85.06 -31.67 22.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.75 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' TRP . 66.7 t -75.37 -55.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.367 0.603 . . . . 0.0 110.37 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.453 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 9.8 t80 -73.82 -58.54 3.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.961 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -69.1 -41.84 76.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -58.24 -29.36 62.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.148 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.8 m -84.54 -47.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 38' ' ' PHE . 14.7 mt -58.66 -40.77 84.44 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.767 0.318 . . . . 0.0 110.63 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.76 -28.67 63.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.9 tp -72.39 -39.23 68.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.005 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.63 -49.56 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.94 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.668 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -63.64 -27.45 71.02 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.793 ' O ' HG23 ' A' ' 51' ' ' VAL . 10.8 t80 -86.37 -33.02 20.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.2 m-85 -76.56 -31.54 57.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.96 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -81.4 -29.59 33.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.55 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' GLY . 28.3 m -78.21 -34.77 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.297 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 47' ' ' PHE . 93.7 t -70.54 -31.68 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.757 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.532 ' HA2' ' HG2' ' A' ' 56' ' ' PRO . . . -94.16 14.92 64.32 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.569 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -118.23 -17.04 9.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.581 0.229 . . . . 0.0 111.595 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 74.9 mmm -140.6 34.06 1.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -145.3 -64.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.6 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 21.3 Cg_exo -60.93 -17.82 53.53 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.496 1.464 . . . . 0.0 110.401 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.662 HG12 ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.09 -52.92 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.208 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.662 ' N ' HG12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -93.15 -44.31 8.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.496 0.665 . . . . 0.0 110.93 178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -32.3 71.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.779 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -113.13 -6.33 13.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.48 178.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.6 mp0 53.47 24.66 4.15 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.978 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.839 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -129.67 136.74 29.56 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.248 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.523 ' C ' ' HD2' ' A' ' 65' ' ' PRO . 58.1 Cg_endo -74.26 -88.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.473 2.115 . . . . 0.0 113.131 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -89.6 -14.23 0.2 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.839 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 95.1 Cg_exo -43.76 -28.43 1.96 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.148 1.899 . . . . 0.0 112.714 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.44 130.31 54.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.737 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.07 -160.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.967 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 48' ' ' PHE . 69.3 p -79.83 -78.59 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.636 0.255 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' N ' ' OG1' ' A' ' 68' ' ' THR . . . 55.12 26.63 43.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.561 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.794 0.33 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.87 160.14 39.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.73 173.65 11.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.57 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.5 ' C ' HG22 ' A' ' 5' ' ' THR . 10.0 ptmm? -62.82 129.27 39.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.33 . . . . 0.0 110.609 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.5 HG22 ' C ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER 159.78 -53.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.43 ' H ' HG23 ' A' ' 5' ' ' THR . 21.5 pt -92.0 -178.69 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 9' ' ' ASP . 8.1 p90 -129.61 31.39 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 44.37 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.651 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' PHE . 36.5 t70 -115.53 -75.84 0.58 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.722 0.296 . . . . 0.0 110.994 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -59.61 141.37 55.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.774 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -68.58 -121.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.348 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.51 ' N ' HD13 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -49.57 -41.0 40.47 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -87.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.189 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER 44.43 85.07 0.18 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.344 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.59 -25.77 76.1 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.696 2.264 . . . . 0.0 112.448 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 11.4 tptp -90.34 -16.85 28.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.121 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.776 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 4.7 m -91.92 -55.7 3.36 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.58 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -52.95 -66.57 0.36 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.76 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -75.78 -42.59 49.77 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.0 111.15 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.657 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -71.82 -31.72 66.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.748 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.902 HD13 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.55 -22.49 43.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.419 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.902 ' N ' HD13 ' A' ' 21' ' ' LEU . 40.5 t90 -82.21 -48.36 11.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 19' ' ' LEU . 12.0 p -65.31 -30.67 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.333 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -83.5 -26.8 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -58.23 -38.88 77.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.712 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.2 pt20 -91.13 -30.57 16.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.476 0.655 . . . . 0.0 110.519 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.73 -34.96 76.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.823 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -34.88 13.17 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.59 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 7.5 ttpp -98.22 -33.89 10.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -84.24 -9.27 82.34 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -90.38 -53.61 4.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.67 0.271 . . . . 0.0 111.612 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.23 -40.16 34.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.8 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 37' ' ' VAL . 7.6 t90 -79.33 -69.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.63 0.253 . . . . 0.0 111.322 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -61.78 -57.98 9.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.253 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -29.53 -46.4 0.09 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.727 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.01 10.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.503 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 33' ' ' TRP . 28.9 t -75.25 -55.41 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.273 0.559 . . . . 0.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.425 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -64.73 -58.29 6.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.201 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 3.1 t80 -59.84 -43.25 94.71 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.039 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.73 -32.19 39.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.197 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.4 m -82.39 -52.19 7.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.844 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 58.2 mt -57.45 -36.59 71.61 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.444 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.19 -30.74 65.25 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.908 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.1 tp -73.06 -50.06 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 mt -82.92 -46.35 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.012 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.929 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -64.41 -34.32 89.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 21.7 t80 -76.69 -33.17 58.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.207 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.752 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -75.46 -32.9 60.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.531 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -29.46 66.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.929 HG23 ' O ' ' A' ' 46' ' ' GLY . 14.0 t -78.33 -30.63 15.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.358 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 48' ' ' PHE . 2.4 p -62.46 -27.91 43.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.795 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.06 -5.43 56.29 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.621 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -137.14 50.13 2.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.741 0.305 . . . . 0.0 111.271 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.745 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 169.82 28.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.87 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.574 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.65 -65.4 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 37.7 Cg_exo -57.41 -17.37 26.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.312 1.342 . . . . 0.0 110.255 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -81.87 -52.3 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.563 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.625 ' H ' HD13 ' A' ' 57' ' ' ILE . 5.5 pt20 -90.34 -18.17 26.03 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.5 tt0 -63.08 -24.03 67.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.62 -9.69 59.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.491 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 65.34 17.76 11.1 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.042 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.849 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -153.21 165.3 17.97 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.641 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 56.8 Cg_endo -70.08 -94.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.295 1.997 . . . . 0.0 112.801 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.73 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -83.68 -22.89 0.32 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.849 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 75.1 Cg_exo -46.24 153.85 0.97 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.266 1.977 . . . . 0.0 112.606 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -169.82 -61.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 mt 67.37 -71.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 t -160.01 -161.36 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.796 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.58 138.42 10.63 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.743 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.195 -179.828 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.847 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.67 120.89 24.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -175.53 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -59.74 -169.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 5' ' ' THR . 10.1 t -91.29 74.37 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.4 mp -100.36 -59.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.492 ' HE2' ' HG1' ' A' ' 17' ' ' THR . 17.7 t80 -167.71 138.1 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.21 135.78 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.42 -29.87 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -59.62 -25.29 64.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.19 -2.89 33.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.619 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 72.23 -152.02 0.08 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.426 0.155 . . . . 0.0 110.684 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -41.27 149.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 111.57 -179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 4.6 t-20 -77.13 -46.98 2.71 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 60.5 Cg_exo -51.03 -25.22 15.82 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.187 1.924 . . . . 0.0 112.431 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.4 tmpt? -56.49 -32.82 65.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.774 ' O ' HD23 ' A' ' 21' ' ' LEU . 82.5 m -90.52 -55.18 3.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.015 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 8.8 m-80 -56.26 -35.01 66.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.458 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.9 tt -75.85 -52.85 9.47 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.292 0.568 . . . . 0.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -53.48 -16.18 1.37 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.817 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.774 HD23 ' O ' ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.15 -62.86 1.51 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.155 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -64.47 -43.27 94.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.837 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 19' ' ' LEU . 22.0 t -56.58 -35.58 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.731 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 28' ' ' MET . . . -79.68 -26.74 40.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.6 -37.47 78.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 1.8 pt20 -91.61 -41.78 10.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 111.63 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -69.21 -39.57 78.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.39 -179.106 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -92.68 -41.83 9.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.751 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 23.8 mtmt -97.08 -29.72 13.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.484 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -87.7 -5.2 78.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -86.46 -60.02 2.11 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.777 0.322 . . . . 0.0 111.706 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.29 -20.85 79.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.049 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.607 ' O ' HG23 ' A' ' 37' ' ' VAL . 55.6 t-105 -78.5 -70.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.714 0.292 . . . . 0.0 111.242 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -57.09 -59.94 4.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.28 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -27.75 -48.28 0.06 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.975 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.52 -39.96 10.35 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.511 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 33' ' ' TRP . 24.4 t -75.28 -55.27 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.159 0.504 . . . . 0.0 111.041 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -65.3 -56.05 14.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.167 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 4.5 t80 -61.4 -41.94 97.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.752 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -54.4 -31.73 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.396 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.475 HG22 HD12 ' A' ' 45' ' ' ILE . 5.0 m -84.39 -47.06 11.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.53 0.205 . . . . 0.0 110.622 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 42' ' ' LEU . 1.8 mt -58.87 -34.97 72.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.22 -33.05 67.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -73.0 -44.06 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.462 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 41' ' ' THR . 12.4 mt -89.22 -42.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -67.29 -30.47 75.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.886 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -83.45 -33.1 25.73 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 109.894 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.712 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -77.1 -31.47 55.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.905 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -76.63 -29.77 56.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.56 -30.86 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 47' ' ' PHE . 64.9 t -63.45 -18.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.751 -0.38 . . . . 0.0 109.992 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.33 -11.35 29.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.363 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -115.89 30.27 7.45 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.104 0.452 . . . . 0.0 111.258 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.711 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -179.56 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.534 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.579 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -147.38 -61.91 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 17.5 Cg_exo -64.11 -17.69 60.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.794 1.663 . . . . 0.0 110.005 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.738 HD13 ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -80.4 -41.41 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.738 ' N ' HD13 ' A' ' 57' ' ' ILE . 16.1 pt20 -90.19 -15.97 30.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 1.3 mt-10 -58.7 -24.49 61.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.338 0.589 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -22.78 66.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.998 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 61.94 28.6 17.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.062 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 65' ' ' PRO . . . -122.89 122.18 27.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.085 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.13 -93.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.23 1.954 . . . . 0.0 112.383 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.668 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -59.67 -46.44 98.56 Favored Pre-proline 0 CA--C 1.53 0.193 0 O-C-N 122.471 -0.143 . . . . 0.0 111.229 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HB2' ' HB1' ' A' ' 62' ' ' ALA . 81.6 Cg_exo -33.32 -60.99 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.215 2.61 . . . . 0.0 113.424 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -168.08 86.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tp -78.27 -30.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 69' ' ' GLY . 9.0 t -124.63 -45.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 68' ' ' THR . . . 70.32 -129.1 19.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.051 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.754 0.311 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.92 159.19 17.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 -167.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.66 137.69 32.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.86 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.14 32.72 21.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.774 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 6' ' ' ILE . 6.2 tt -155.65 52.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 111.181 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.92 37.07 1.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.679 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -108.99 33.16 4.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -94.82 -53.48 3.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -89.81 -60.23 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -151.59 -179.18 7.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -63.43 -68.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.766 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -57.66 168.63 0.83 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -172.58 67.05 0.38 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.56 -25.22 48.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.494 2.129 . . . . 0.0 111.912 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.77 -27.23 64.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.038 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.858 ' O ' HD21 ' A' ' 21' ' ' LEU . 30.2 m -74.61 -21.04 59.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.187 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.715 ' HA ' HD21 ' A' ' 21' ' ' LEU . 37.9 m-20 -97.96 -42.43 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.865 0.364 . . . . 0.0 111.947 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.947 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -75.16 -32.73 61.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.503 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.636 ' NH2' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -64.96 -33.61 76.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.858 HD21 ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -83.46 -30.78 26.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.265 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.94 -44.71 76.2 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 19' ' ' LEU . 52.6 t -64.48 -33.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.195 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -79.62 -26.78 41.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -43.44 89.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.67 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -89.68 -28.47 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.431 0.634 . . . . 0.0 110.14 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -68.42 -31.89 71.55 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.528 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 ttp -92.55 -33.4 14.46 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.097 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.95 -18.99 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 110.19 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -103.33 -9.67 38.19 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.943 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.647 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -96.11 -45.56 6.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 0.0 111.651 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.73 -47.83 9.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -63.65 -56.69 13.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.263 . . . . 0.0 111.338 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -53.1 -61.85 2.03 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.409 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -22.7 -53.78 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.972 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -44.16 9.52 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -75.31 -55.3 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.222 0.534 . . . . 0.0 111.062 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -59.51 -58.63 7.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.054 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 2.7 t80 -53.6 -43.72 68.85 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.258 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -54.55 -31.26 52.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.603 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 45' ' ' ILE . 12.9 m -85.64 -45.05 12.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.823 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 38' ' ' PHE . 9.7 mt -60.9 -35.9 77.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 110.523 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.56 -31.88 65.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.989 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 tp -72.45 -45.23 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.507 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 41' ' ' THR . 8.9 mt -85.7 -41.8 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -68.62 -31.15 73.15 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.646 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 42.0 t80 -79.95 -32.44 39.98 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.91 0.386 . . . . 0.0 110.467 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.615 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -76.37 -51.98 10.82 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -29.72 68.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -80.16 -33.79 14.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.173 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -60.41 -21.85 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.408 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.54 -9.26 31.39 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.247 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.4 41.55 3.49 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.974 0.387 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.683 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 170.53 31.45 0.0 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.619 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.558 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.96 -65.49 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 38.9 Cg_exo -55.69 -17.58 18.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.29 1.327 . . . . 0.0 110.235 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -81.26 -55.26 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.57 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.615 ' H ' HD13 ' A' ' 57' ' ' ILE . 10.1 pt20 -91.01 -18.16 25.08 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.4 tp10 -60.58 -22.46 63.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' OD1' ' ND2' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -63.35 -27.95 69.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.884 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 55.96 32.96 20.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.259 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 65' ' ' PRO . . . -151.91 121.98 3.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 56.8 Cg_endo -81.54 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.319 2.013 . . . . 0.0 113.061 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.707 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -68.02 -29.3 2.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 38.5 Cg_exo -56.89 -147.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.614 2.209 . . . . 0.0 112.172 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 1.3 m120 74.01 -67.71 0.25 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 66' ' ' ASN . 2.5 pp -156.86 -179.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.444 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.403 ' O ' HD12 ' A' ' 67' ' ' ILE . 16.8 p -79.89 137.6 36.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.845 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.38 138.92 3.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.449 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.095 179.949 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.42 142.35 33.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.55 -76.38 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -89.96 -177.9 5.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 5' ' ' THR . 10.6 t -86.61 55.86 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.973 0.416 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.34 9.4 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.44 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 57.6 57.61 4.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.52 -164.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -49.58 -53.39 24.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -61.42 118.08 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.7 pt? -125.02 -164.31 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.788 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.51 -64.32 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 t -88.76 86.5 6.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -133.75 66.65 73.57 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.68 -25.05 57.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 112.514 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -74.67 -33.8 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 111.039 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.929 ' O ' HD12 ' A' ' 21' ' ' LEU . 84.9 m -90.18 -21.91 21.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.32 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.56 -66.98 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.884 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.72 -52.88 8.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.824 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.89 -31.94 73.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.937 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.21 -26.19 42.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.692 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.894 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.7 t90 -82.28 -37.7 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.5 t -63.5 -37.14 78.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.611 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.61 -26.79 41.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -63.28 -35.67 81.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.209 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.59 -40.28 11.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.222 0.534 . . . . 0.0 111.108 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.2 -43.22 67.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.339 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.6 ttp -92.35 -41.73 10.19 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.551 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.812 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 1.7 ttpt -96.07 -32.38 12.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -85.01 -4.13 87.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.38 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -88.2 -59.6 2.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.37 62.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.012 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.413 ' CE3' ' HA ' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -82.34 -69.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.362 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -47.69 -28.64 2.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.68 -57.54 13.84 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.023 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.76 -31.18 24.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t -75.35 -55.11 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 110.722 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -71.65 -58.16 3.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.853 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -63.0 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.63 -31.18 66.7 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.14 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 m -82.5 -46.21 13.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 0.0 110.415 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 39' ' ' PHE . 5.2 mt -60.4 -38.09 82.89 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.92 -28.9 63.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.898 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.6 tp -72.85 -44.79 60.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.945 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 mt -87.85 -49.5 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.29 -24.33 65.36 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.565 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.5 t80 -88.86 -33.05 17.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.975 0.417 . . . . 0.0 110.106 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -32.86 64.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -79.61 -34.12 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.713 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' GLY . 29.1 m -80.39 -30.69 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.376 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 47' ' ' PHE . 78.7 t -74.94 -29.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 13.6 65.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.507 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 29.5 tpt85 -122.23 -15.26 7.74 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.463 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.45 45.57 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.634 HD23 ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -153.89 -66.84 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.634 ' HD3' HD23 ' A' ' 55' ' ' LEU . 36.5 Cg_exo -52.53 -17.84 7.39 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.663 1.575 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.747 HG12 ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -67.46 -57.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.685 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.747 ' N ' HG12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -92.91 -37.38 12.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.9 -28.45 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.932 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -113.69 -16.57 12.29 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.296 178.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER 54.1 23.01 3.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.807 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.763 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -153.01 167.98 12.35 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 19.2 Cg_endo -58.75 -160.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.467 2.111 . . . . 0.0 112.351 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.647 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -66.68 -27.17 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 84.2 Cg_exo -46.35 99.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.423 2.082 . . . . 0.0 112.696 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -173.51 174.12 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.58 137.47 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.46 169.16 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.799 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.78 76.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.777 0.323 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.34 150.37 49.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 75.03 -62.47 0.45 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.516 ' C ' HG23 ' A' ' 5' ' ' THR . 4.1 pttt -80.79 141.89 34.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.671 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.516 HG23 ' C ' ' A' ' 4' ' ' LYS . 1.1 p 70.21 10.66 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.472 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 tt -162.6 147.41 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.752 0.31 . . . . 0.0 111.154 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -57.91 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.52 150.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.878 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.25 169.19 5.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -68.4 71.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.96 69.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.524 ' O ' HG22 ' A' ' 13' ' ' THR . 54.4 t-20 62.1 110.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER 72.59 178.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.547 ' N ' HG23 ' A' ' 13' ' ' THR . 12.7 t30 173.1 -47.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.765 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HB2' HD22 ' A' ' 19' ' ' LEU . 39.4 Cg_exo -60.94 -10.04 13.67 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.418 2.079 . . . . 0.0 112.56 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -49.21 -27.09 3.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.921 ' O ' HD21 ' A' ' 21' ' ' LEU . 31.6 m -91.64 -22.71 20.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.669 ' O ' HD22 ' A' ' 21' ' ' LEU . 4.8 m-80 -101.57 -57.8 2.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.25 -31.29 62.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.304 -178.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.04 -38.96 92.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.921 HD21 ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.02 -23.1 44.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.738 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.471 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -76.96 -55.23 5.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 19' ' ' LEU . 44.4 t -57.45 -29.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.34 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' ' CG ' ' A' ' 27' ' ' MET . . . -78.35 -26.08 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.097 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' CA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -71.37 -30.27 65.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.099 -179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.87 -37.48 12.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 112.037 -179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.763 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -65.32 -37.19 86.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.298 0.571 . . . . 0.0 111.163 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.7 ttp -92.71 -41.59 10.07 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.113 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE2' ' CA ' ' A' ' 25' ' ' PHE . 3.2 mtmm -95.4 -43.99 7.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.115 0.483 . . . . 0.0 110.096 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -70.63 -13.14 71.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.114 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -77.8 -45.76 23.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.766 0.317 . . . . 0.0 111.547 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.77 -35.05 66.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.709 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -71.47 -71.97 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.604 0.24 . . . . 0.0 111.32 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.73 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -45.82 -58.76 3.24 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.439 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -23.74 -50.64 0.02 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.565 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -78.82 -47.99 7.41 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.389 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 t -75.15 -55.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.378 0.609 . . . . 0.0 110.991 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.73 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -55.64 -58.08 9.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.022 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 1.1 t80 -53.95 -43.16 69.63 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.172 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . -54.75 -31.25 53.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.347 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.456 HG22 HD12 ' A' ' 45' ' ' ILE . 11.1 m -84.61 -48.28 9.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.684 0.278 . . . . 0.0 110.703 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD11 ' CD2' ' A' ' 38' ' ' PHE . 22.2 mt -58.66 -36.64 74.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.14 -31.9 66.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.925 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.63 -45.87 56.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.87 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 41' ' ' THR . 15.9 mt -87.73 -48.57 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 50' ' ' VAL . . . -62.67 -28.79 72.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -84.86 -33.26 22.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -73.05 -35.9 66.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -75.72 -32.85 60.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.408 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' GLY . 9.8 p -80.74 -30.13 11.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.469 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 47' ' ' PHE . 66.0 t -68.38 -9.73 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.94 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.77 -14.53 9.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.444 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 54' ' ' MET . 3.6 ttt85 -105.55 3.84 29.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.144 0.472 . . . . 0.0 111.757 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.639 ' HA ' HD12 ' A' ' 57' ' ' ILE . 3.6 mmt -163.57 47.66 0.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.802 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -151.77 -61.82 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 35.9 Cg_exo -58.6 -17.6 35.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 121.629 1.553 . . . . 0.0 110.351 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -80.68 -50.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.137 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.601 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.8 -14.52 31.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.423 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -61.73 -20.84 63.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.012 0.434 . . . . 0.0 109.902 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -24.9 30.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.393 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 24.95 8.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.209 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.643 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . . . -73.15 136.64 79.09 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.917 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.96 -97.58 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.178 1.919 . . . . 0.0 112.173 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.696 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -61.87 -46.12 92.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.388 0.137 . . . . 0.0 111.25 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 64' ' ' ALA . 76.2 Cg_exo -34.72 -34.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.248 2.632 . . . . 0.0 113.305 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 62' ' ' ALA . 13.7 m-20 -112.08 123.29 49.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.873 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.1 pt -61.49 144.94 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.4 m -87.76 125.82 34.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.03 -40.73 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.493 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.094 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.79 118.89 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -179.23 -78.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 170.06 10.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.756 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 6' ' ' ILE . 18.0 p -75.85 63.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 7' ' ' PHE . 3.0 mp 60.81 158.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.48 ' N ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.06 -167.39 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 62.54 96.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -137.02 -160.78 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.743 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.723 ' HB3' HD23 ' A' ' 11' ' ' LEU . 19.7 t-80 -44.9 -38.74 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.824 0.345 . . . . 0.0 111.474 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.723 HD23 ' HB3' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -135.13 160.49 38.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -81.47 60.83 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 13' ' ' THR . 8.7 t -100.99 78.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -132.42 67.54 78.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.75 -25.38 60.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.104 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -27.85 64.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -90.41 -55.24 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.684 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.674 ' HA ' HD21 ' A' ' 21' ' ' LEU . 9.2 m-80 -43.5 -43.96 5.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.048 0.451 . . . . 0.0 111.39 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 tp -74.04 -31.18 62.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.824 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -61.87 -39.49 92.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.44 -30.83 42.41 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.092 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 5.9 t90 -71.1 -41.13 70.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 19' ' ' LEU . 70.4 t -67.64 -31.58 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.147 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.7 -26.67 40.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.627 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -70.64 -31.72 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.722 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -92.06 -29.15 16.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.763 0.792 . . . . 0.0 109.798 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.698 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.03 -34.0 74.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.805 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.7 ttp -94.19 -40.18 10.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.148 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -95.08 -39.25 10.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.492 0.663 . . . . 0.0 110.625 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.82 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -79.34 -13.31 82.89 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.598 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -77.44 -55.66 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.32 -46.61 19.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.661 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -76.17 -69.83 0.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.575 0.226 . . . . 0.0 111.378 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -56.73 -54.06 50.58 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.056 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -27.86 -46.97 0.05 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.469 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -79.4 -46.85 7.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.917 -0.658 . . . . 0.0 113.357 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.2 t -75.18 -55.31 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.442 0.639 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.552 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -59.77 -58.0 10.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.399 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HA ' HD12 ' A' ' 42' ' ' LEU . 1.9 t80 -56.68 -41.62 77.63 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 43' ' ' LEU . . . -55.47 -34.04 59.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.626 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.477 HG22 HD12 ' A' ' 45' ' ' ILE . 10.4 m -83.08 -44.67 14.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.683 0.278 . . . . 0.0 110.635 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 39' ' ' PHE . 4.8 mt -60.82 -35.5 76.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.861 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.59 -30.32 64.28 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.914 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.3 tp -72.93 -50.18 25.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.028 0.442 . . . . 0.0 110.927 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 41' ' ' THR . 9.5 mt -81.48 -47.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.587 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.36 -23.56 64.64 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.795 ' O ' HG23 ' A' ' 51' ' ' VAL . 64.6 t80 -81.54 -33.7 31.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -32.55 39.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.75 -32.43 62.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.469 -179.316 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG12 ' SD ' ' A' ' 54' ' ' MET . 35.1 m -81.4 -27.64 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.192 0.52 . . . . 0.0 111.743 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 47' ' ' PHE . 67.0 t -80.77 -5.56 8.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.06 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.82 18.75 4.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 27.6 ttt-85 -155.58 -46.0 0.08 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.282 0.563 . . . . 0.0 110.883 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.678 ' HA ' HD12 ' A' ' 57' ' ' ILE . 35.9 mtp -109.97 59.27 0.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.97 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -155.27 -59.07 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 22.1 Cg_exo -62.84 -17.48 59.72 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.793 1.662 . . . . 0.0 110.226 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.694 HD13 ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -84.42 -38.09 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.585 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.694 ' N ' HD13 ' A' ' 57' ' ' ILE . 5.8 pt20 -90.07 -16.41 29.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.17 -24.05 66.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.354 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -67.86 -29.04 68.07 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.207 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.46 14.26 9.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.667 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -153.08 160.04 31.46 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.819 0.343 . . . . 0.0 111.336 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.549 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 27.5 Cg_endo -62.83 -162.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.418 2.079 . . . . 0.0 112.181 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.703 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -70.86 -22.51 0.6 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.703 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 23.1 Cg_exo -62.45 3.93 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.725 2.283 . . . . 0.0 113.491 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.75 66.0 0.34 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.925 0.393 . . . . 0.0 110.51 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.08 163.68 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.183 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -107.67 -31.04 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.93 177.37 14.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 0.0 111.066 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.29 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.628 ' O ' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -176.24 -165.22 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -78.86 129.9 35.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t 43.09 68.89 0.44 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.542 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.628 HD11 ' O ' ' A' ' 3' ' ' ASP . 0.9 OUTLIER -83.55 139.14 18.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HA ' HG21 ' A' ' 17' ' ' THR . 11.0 t80 -84.1 -108.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 48.67 -171.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.824 0.345 . . . . 0.0 111.104 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.06 -72.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' CD2' ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -60.68 -176.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -84.22 -168.12 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -69.51 85.3 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 p -147.07 -148.17 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.727 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -177.24 -52.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 CA-C-O 120.463 0.173 . . . . 0.0 111.238 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 84.7 Cg_exo -49.33 -24.15 8.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.975 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -68.95 -52.88 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 111.148 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.749 ' O ' HD23 ' A' ' 21' ' ' LEU . 89.0 m -90.57 -22.09 21.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.85 0.357 . . . . 0.0 111.407 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.42 -61.43 1.7 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -76.1 -53.03 8.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.642 HH21 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -52.25 -17.99 1.36 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.816 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 17' ' ' THR . 1.2 mm? -77.94 -63.18 1.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -61.11 -44.48 97.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.845 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 19' ' ' LEU . 26.3 t -51.37 -31.84 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 27' ' ' MET . . . -79.42 -26.37 41.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.847 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.828 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.04 -29.35 70.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.551 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 23' ' ' VAL . 2.9 pm0 -91.15 -37.09 13.59 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.891 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.97 -36.66 23.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.261 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.4 ttp -91.9 -43.61 9.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.828 0.347 . . . . 0.0 111.205 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.828 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.3 mtmt -93.8 -31.18 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -88.13 0.59 84.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.41 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -88.93 -59.43 2.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.69 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.81 -36.21 42.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.129 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.853 ' CD1' HG21 ' A' ' 37' ' ' VAL . 48.6 t90 -73.42 -68.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -44.26 -73.27 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -18.03 -60.64 0.01 OUTLIER Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.031 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 -40.64 11.54 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.943 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.853 HG21 ' CD1' ' A' ' 33' ' ' TRP . 60.4 t -75.3 -55.41 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.16 0.505 . . . . 0.0 111.178 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -60.08 -58.39 8.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.079 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -69.65 -41.66 75.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.699 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 39' ' ' PHE . . . -57.54 -31.48 63.46 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.21 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 84.9 m -84.34 -46.25 11.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.243 . . . . 0.0 110.657 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 39' ' ' PHE . 3.1 mt -60.57 -38.58 85.05 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.893 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.94 -29.14 63.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.893 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.5 tp -72.95 -48.23 38.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.907 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.32 -48.17 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.329 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.985 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -62.26 -33.6 86.55 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.301 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.604 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -79.15 -32.82 44.43 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -40.03 49.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -28.88 67.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 46' ' ' GLY . 93.0 t -69.13 -46.4 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 47' ' ' PHE . 25.3 t -56.69 -30.26 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.222 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA2' ' HG2' ' A' ' 56' ' ' PRO . . . -87.94 3.78 85.79 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.453 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.19 4.42 15.53 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.633 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -156.18 30.62 0.34 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -147.76 -64.16 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.525 ' HG2' ' HA2' ' A' ' 52' ' ' GLY . 25.7 Cg_exo -57.65 -17.29 28.09 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.13 1.22 . . . . 0.0 109.763 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -86.37 -55.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.386 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.63 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -91.28 -34.13 15.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' LEU . 21.7 tp10 -65.31 -31.06 71.99 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.113 0.483 . . . . 0.0 109.975 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -86.23 -24.15 26.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.363 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 51.16 26.25 2.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.86 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -148.21 173.2 4.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 60.6 Cg_endo -88.64 -88.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.803 2.335 . . . . 0.0 113.073 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' CD ' ' A' ' 65' ' ' PRO . . . -60.74 -61.66 7.53 Favored Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.625 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 4.8 Cg_exo -38.66 93.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.388 2.726 . . . . 0.0 112.965 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 64' ' ' ALA . 69.3 m-20 -139.95 -170.24 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -129.25 54.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 t -136.06 143.49 44.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.88 -79.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.5 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.827 0.346 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.94 157.25 45.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.626 ' O ' HG23 ' A' ' 6' ' ' ILE . 10.4 p-10 -140.88 178.39 7.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 m 69.86 -72.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 3' ' ' ASP . 30.5 pt 40.81 57.42 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.645 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.55 157.07 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -166.56 179.21 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.771 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.91 -162.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.674 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -50.97 95.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.078 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.8 165.26 16.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.852 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.58 -59.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -177.77 101.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.981 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' C ' HD21 ' A' ' 18' ' ' ASN . 8.0 p-10 -108.04 145.1 30.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.35 -34.69 81.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.556 2.171 . . . . 0.0 112.599 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.57 -58.6 5.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.436 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.659 ' O ' HD23 ' A' ' 21' ' ' LEU . 97.1 m -67.95 -30.21 69.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.839 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 2.6 m-80 -51.21 -66.48 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.005 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.86 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.3 tt -76.17 -43.02 44.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.86 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 4.4 tpm_? -52.48 -29.97 27.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.673 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 22' ' ' TRP . 4.2 pp -78.7 -41.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.887 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.713 ' N ' HD12 ' A' ' 21' ' ' LEU . 24.5 t90 -61.96 -45.31 94.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 19' ' ' LEU . 13.0 t -60.28 -30.18 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.342 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.21 -26.79 42.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.938 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -45.61 92.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.893 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.54 -28.57 18.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 179.505 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.706 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.99 -31.61 70.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.838 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -38.78 11.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.563 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -50.79 5.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 109.53 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.81 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -63.43 -20.68 63.7 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.492 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -80.03 -57.18 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.61 -67.74 1.79 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.973 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -48.47 -64.22 0.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -51.43 -61.65 2.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.348 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -23.36 -52.83 0.03 OUTLIER Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.891 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -79.45 -44.45 9.49 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.678 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 34' ' ' ALA . 22.0 t -74.68 -55.44 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.24 0.543 . . . . 0.0 111.209 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -61.96 -59.28 5.33 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.885 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.643 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 8.4 t80 -49.55 -39.64 35.46 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 122.252 -0.28 . . . . 0.0 111.191 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -52.04 -44.87 56.89 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.103 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.7 m -82.35 -53.35 6.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.181 0.515 . . . . 0.0 110.734 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -49.98 -45.58 51.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.344 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.883 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.11 -30.41 65.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.718 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.883 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.6 tp -73.06 -47.45 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.044 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mt -80.51 -46.58 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.539 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -66.13 -43.22 93.68 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.0 t80 -66.66 -32.85 74.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.094 0.474 . . . . 0.0 109.86 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 4.4 m-30 -75.35 -30.3 60.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.947 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.07 -28.97 57.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 46' ' ' GLY . 2.5 t -80.25 -29.86 12.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.58 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 47' ' ' PHE . 21.8 t -72.5 -12.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.864 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.42 4.36 13.5 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.24 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 ttt-85 -158.74 41.49 0.24 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.961 0.381 . . . . 0.0 111.732 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.742 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 167.8 48.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.919 -179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -154.63 -60.54 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 23.4 Cg_exo -61.95 -17.83 57.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.744 1.629 . . . . 0.0 110.302 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.787 HD13 ' H ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -80.42 -38.86 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.315 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.787 ' H ' HD13 ' A' ' 57' ' ' ILE . 7.0 pt20 -90.27 -12.27 38.38 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.979 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -25.74 59.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.77 -20.75 62.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.239 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 73.05 31.51 1.47 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.902 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -153.13 132.28 6.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.26 -77.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.373 2.049 . . . . 0.0 112.277 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.745 ' N ' ' HD3' ' A' ' 65' ' ' PRO . . . -145.72 45.13 0.46 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.902 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 4.5 Cg_endo -87.77 -16.86 2.83 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.915 2.41 . . . . 0.0 112.031 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.94 129.28 48.17 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.238 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -103.19 145.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.9 -84.89 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.703 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.26 98.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.623 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.777 0.322 . . . . 0.0 111.018 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.838 0.351 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.12 175.02 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.92 -178.23 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 173.04 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.84 -65.66 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -70.72 152.92 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -53.79 149.05 9.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -70.5 -46.71 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 68.5 72.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -48.42 77.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.11 -60.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.64 37.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.616 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.05 95.81 5.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 3.7 t30 -79.65 -34.89 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.964 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 14' ' ' ASN . 88.7 Cg_exo -48.4 -23.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.302 2.001 . . . . 0.0 112.816 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.95 -27.41 7.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 110.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.8 m -90.38 -55.48 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 23.2 m-20 -46.89 -35.47 6.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.121 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 tp -75.61 -52.36 10.75 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.427 0.632 . . . . 0.0 110.083 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -52.36 -16.76 0.93 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.746 178.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -77.58 -63.07 1.46 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.793 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.26 -34.29 77.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.821 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 19' ' ' LEU . 40.3 t -65.5 -34.14 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.658 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.58 -26.9 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -42.3 99.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.959 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 pt20 -91.07 -28.9 17.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.088 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.749 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.967 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.5 ttm -93.45 -41.66 9.68 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.09 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HE3' ' N ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -93.62 -39.75 10.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.413 0.625 . . . . 0.0 110.41 -178.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 34' ' ' ALA . . . -80.72 -8.2 87.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.846 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -82.37 -60.14 2.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.57 -33.82 33.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.948 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -90.2 -65.95 0.97 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HB3' ' HA2' ' A' ' 30' ' ' GLY . . . -65.72 -34.11 77.44 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 111.009 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . -50.56 -60.35 6.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.314 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 -40.14 14.06 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.38 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 33' ' ' TRP . 39.8 t -74.55 -55.37 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.144 0.497 . . . . 0.0 111.456 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -66.19 -59.46 3.74 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.522 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.69 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 23.4 t80 -44.7 -45.2 9.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.065 0.393 . . . . 0.0 111.414 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . -49.52 -48.6 34.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.448 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 45' ' ' ILE . 25.8 m -81.61 -53.77 5.97 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.061 0.458 . . . . 0.0 111.218 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.887 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.31 -44.07 54.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.603 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.93 -31.51 66.42 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.896 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.6 tp -73.21 -49.99 24.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.389 0.614 . . . . 0.0 110.691 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 41' ' ' THR . 31.2 mt -81.01 -52.14 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.141 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -60.58 -28.88 68.42 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.846 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.5 t80 -79.66 -32.98 41.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.061 0.458 . . . . 0.0 110.014 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -31.92 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -29.87 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.648 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 46' ' ' GLY . 33.7 m -81.12 -28.55 10.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.509 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 47' ' ' PHE . 65.0 t -74.66 -12.23 14.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.529 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.82 21.19 4.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.021 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -172.98 28.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.696 0.284 . . . . 0.0 111.542 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.844 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER 179.82 40.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.134 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -147.48 -64.72 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 27.7 Cg_exo -57.45 -17.55 27.87 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.266 1.311 . . . . 0.0 109.849 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.988 HD13 ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.65 -35.93 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.948 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.988 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -90.39 -16.64 28.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.638 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -68.39 -18.32 64.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.81 23.85 6.68 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.413 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 70.48 143.8 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.433 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -54.26 157.52 4.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.379 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 57.0 Cg_endo -70.78 71.48 2.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.622 2.215 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB3' ' CD ' ' A' ' 65' ' ' PRO . . . -176.63 -62.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.379 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.605 ' CD ' ' HB3' ' A' ' 64' ' ' ALA . 2.5 Cg_endo -45.08 -51.77 7.23 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.847 2.365 . . . . 0.0 112.692 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -108.79 -29.98 8.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.068 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.12 62.98 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -131.87 -47.39 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.824 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.27 27.42 30.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.547 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 111.031 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.2 tt -75.56 -37.63 59.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -39.74 94.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.35 -18.14 53.05 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.848 ' N ' HD13 ' A' ' 21' ' ' LEU . 5.6 t90 -84.43 -42.91 15.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 19' ' ' LEU . 69.1 t -63.22 -32.7 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.213 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.63 -26.67 41.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.755 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -61.41 -42.77 99.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.1 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.61 -29.7 17.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.68 0.752 . . . . 0.0 109.714 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.637 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.92 -31.85 69.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.181 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.1 ttp -93.01 -41.2 10.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.087 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HE2' ' CD1' ' A' ' 25' ' ' PHE . 9.5 mtpt -91.4 -58.16 2.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -51.76 -27.2 19.27 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.859 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.699 0.285 . . . . 0.0 111.314 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.8 m -84.54 -47.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.66 -40.77 84.44 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.767 0.318 . . . . 0.0 110.63 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.76 -28.67 63.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.9 tp -72.39 -39.23 68.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.005 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.63 -49.56 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.94 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.668 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -63.64 -27.45 71.02 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 10.8 t80 -86.37 -33.02 20.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.2 m-85 -76.56 -31.54 57.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.96 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -81.4 -29.59 33.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.55 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' GLY . 28.3 m . . . . . 0 CA--C 1.518 -0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.297 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.76 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -75.78 -42.59 49.77 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.0 111.15 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.657 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -71.82 -31.72 66.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.748 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.902 HD13 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.55 -22.49 43.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.419 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.902 ' N ' HD13 ' A' ' 21' ' ' LEU . 40.5 t90 -82.21 -48.36 11.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 19' ' ' LEU . 12.0 p -65.31 -30.67 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.333 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -83.5 -26.8 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -58.23 -38.88 77.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.712 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.13 -30.57 16.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.476 0.655 . . . . 0.0 110.519 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.73 -34.96 76.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.823 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -34.88 13.17 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.59 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 7.5 ttpp -98.22 -33.89 10.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -84.24 -9.27 82.34 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.67 0.271 . . . . 0.0 111.612 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.4 m -82.39 -52.19 7.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.844 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 58.2 mt -57.45 -36.59 71.61 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.444 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.19 -30.74 65.25 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.908 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.1 tp -73.06 -50.06 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 mt -82.92 -46.35 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.012 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.929 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -64.41 -34.32 89.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 21.7 t80 -76.69 -33.17 58.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.207 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -75.46 -32.9 60.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.531 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -29.46 66.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.929 HG23 ' O ' ' A' ' 46' ' ' GLY . 14.0 t . . . . . 0 C--O 1.221 -0.413 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 8.8 m-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.9 tt -75.85 -52.85 9.47 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.292 0.568 . . . . 0.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -53.48 -16.18 1.37 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.817 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -77.15 -62.86 1.51 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.155 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -64.47 -43.27 94.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.837 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 19' ' ' LEU . 22.0 t -56.58 -35.58 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.731 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 28' ' ' MET . . . -79.68 -26.74 40.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.6 -37.47 78.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.61 -41.78 10.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 111.63 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -69.21 -39.57 78.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.39 -179.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -92.68 -41.83 9.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.751 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 23.8 mtmt -97.08 -29.72 13.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.484 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -87.7 -5.2 78.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.777 0.322 . . . . 0.0 111.706 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.475 HG22 HD12 ' A' ' 45' ' ' ILE . 5.0 m -84.39 -47.06 11.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.53 0.205 . . . . 0.0 110.622 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 42' ' ' LEU . 1.8 mt -58.87 -34.97 72.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.22 -33.05 67.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -73.0 -44.06 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.462 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 41' ' ' THR . 12.4 mt -89.22 -42.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -67.29 -30.47 75.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -83.45 -33.1 25.73 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 109.894 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.712 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -77.1 -31.47 55.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.905 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -76.63 -29.77 56.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.917 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.715 ' HA ' HD21 ' A' ' 21' ' ' LEU . 37.9 m-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.947 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -75.16 -32.73 61.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.503 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.636 ' NH2' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -64.96 -33.61 76.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.837 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -83.46 -30.78 26.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.265 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.94 -44.71 76.2 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 19' ' ' LEU . 52.6 t -64.48 -33.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.195 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -79.62 -26.78 41.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -43.44 89.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.67 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -89.68 -28.47 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.431 0.634 . . . . 0.0 110.14 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -68.42 -31.89 71.55 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.528 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 ttp -92.55 -33.4 14.46 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.097 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.95 -18.99 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 110.19 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -103.33 -9.67 38.19 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.943 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.647 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 0.0 111.651 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 45' ' ' ILE . 12.9 m -85.64 -45.05 12.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.823 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.9 -35.9 77.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 110.523 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.56 -31.88 65.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.989 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 tp -72.45 -45.23 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.507 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 41' ' ' THR . 8.9 mt -85.7 -41.8 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -68.62 -31.15 73.15 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.646 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 42.0 t80 -79.95 -32.44 39.98 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.91 0.386 . . . . 0.0 110.467 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.37 -51.98 10.82 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -29.72 68.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.173 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.72 -52.88 8.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.824 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.89 -31.94 73.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.937 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.21 -26.19 42.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.692 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.894 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.7 t90 -82.28 -37.7 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.5 t -63.5 -37.14 78.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.611 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.61 -26.79 41.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -63.28 -35.67 81.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.209 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.59 -40.28 11.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.222 0.534 . . . . 0.0 111.108 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.2 -43.22 67.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.339 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.6 ttp -92.35 -41.73 10.19 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.551 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.812 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 1.7 ttpt -96.07 -32.38 12.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -85.01 -4.13 87.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.38 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 m -82.5 -46.21 13.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 0.0 110.415 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLY . 5.2 mt -60.4 -38.09 82.89 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.92 -28.9 63.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.898 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.6 tp -72.85 -44.79 60.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.945 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 mt -87.85 -49.5 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.29 -24.33 65.36 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.565 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.612 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 6.5 t80 -88.86 -33.05 17.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.975 0.417 . . . . 0.0 110.106 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -32.86 64.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -34.12 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.713 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' GLY . 29.1 m . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.376 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.669 ' O ' HD22 ' A' ' 21' ' ' LEU . 4.8 m-80 . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.25 -31.29 62.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.304 -178.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.04 -38.96 92.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.75 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.02 -23.1 44.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.738 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.471 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -76.96 -55.23 5.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 19' ' ' LEU . 44.4 t -57.45 -29.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.34 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' ' CG ' ' A' ' 27' ' ' MET . . . -78.35 -26.08 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.097 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' CA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -71.37 -30.27 65.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.099 -179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.87 -37.48 12.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 112.037 -179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.763 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -65.32 -37.19 86.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.298 0.571 . . . . 0.0 111.163 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.7 ttp -92.71 -41.59 10.07 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.113 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE2' ' CA ' ' A' ' 25' ' ' PHE . 3.2 mtmm -95.4 -43.99 7.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.115 0.483 . . . . 0.0 110.096 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -70.63 -13.14 71.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.114 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.333 -0.129 0 CA-C-O 120.766 0.317 . . . . 0.0 111.547 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.456 HG22 HD12 ' A' ' 45' ' ' ILE . 11.1 m -84.61 -48.28 9.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.684 0.278 . . . . 0.0 110.703 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 46' ' ' GLY . 22.2 mt -58.66 -36.64 74.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.14 -31.9 66.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.925 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.63 -45.87 56.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.87 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 41' ' ' THR . 15.9 mt -87.73 -48.57 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 50' ' ' VAL . . . -62.67 -28.79 72.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -84.86 -33.26 22.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -73.05 -35.9 66.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -75.72 -32.85 60.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.408 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' GLY . 9.8 p . . . . . 0 C--O 1.222 -0.352 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.469 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.674 ' HA ' HD21 ' A' ' 21' ' ' LEU . 9.2 m-80 . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 121.048 0.451 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 tp -74.04 -31.18 62.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.824 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -61.87 -39.49 92.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.44 -30.83 42.41 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.092 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 5.9 t90 -71.1 -41.13 70.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 19' ' ' LEU . 70.4 t -67.64 -31.58 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.147 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.7 -26.67 40.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.627 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -70.64 -31.72 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.722 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -92.06 -29.15 16.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.763 0.792 . . . . 0.0 109.798 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.698 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.03 -34.0 74.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.805 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.7 ttp -94.19 -40.18 10.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.148 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -95.08 -39.25 10.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.492 0.663 . . . . 0.0 110.625 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -79.34 -13.31 82.89 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.598 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.309 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.477 HG22 HD12 ' A' ' 45' ' ' ILE . 10.4 m -83.08 -44.67 14.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.683 0.278 . . . . 0.0 110.635 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 4.8 mt -60.82 -35.5 76.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.861 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.59 -30.32 64.28 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.914 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.3 tp -72.93 -50.18 25.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.028 0.442 . . . . 0.0 110.927 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 41' ' ' THR . 9.5 mt -81.48 -47.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.587 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.36 -23.56 64.64 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.72 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 64.6 t80 -81.54 -33.7 31.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -32.55 39.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.75 -32.43 62.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.469 -179.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 46' ' ' GLY . 35.1 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.192 0.52 . . . . 0.0 111.743 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.2 t30 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -76.1 -53.03 8.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.642 HH21 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -52.25 -17.99 1.36 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.816 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' A' ' 19' ' ' LEU . 1.2 mm? -77.94 -63.18 1.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 4.5 t90 -61.11 -44.48 97.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.845 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 19' ' ' LEU . 26.3 t -51.37 -31.84 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 27' ' ' MET . . . -79.42 -26.37 41.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.847 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.828 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.04 -29.35 70.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.551 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.15 -37.09 13.59 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.891 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.97 -36.66 23.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.261 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.4 ttp -91.9 -43.61 9.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.828 0.347 . . . . 0.0 111.205 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.828 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.3 mtmt -93.8 -31.18 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.13 0.59 84.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.41 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.69 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 84.9 m -84.34 -46.25 11.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.243 . . . . 0.0 110.657 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 46' ' ' GLY . 3.1 mt -60.57 -38.58 85.05 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.893 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.94 -29.14 63.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.893 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.5 tp -72.95 -48.23 38.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.907 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.32 -48.17 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.329 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.985 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -62.26 -33.6 86.55 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.301 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.15 -32.82 44.43 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -40.03 49.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -28.88 67.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 46' ' ' GLY . 93.0 t . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 1.1 m120 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.975 0.417 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.86 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.3 tt -76.17 -43.02 44.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.86 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -52.48 -29.97 27.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.673 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 22' ' ' TRP . 4.2 pp -78.7 -41.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.887 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.713 ' N ' HD12 ' A' ' 21' ' ' LEU . 24.5 t90 -61.96 -45.31 94.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 19' ' ' LEU . 13.0 t -60.28 -30.18 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.342 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.21 -26.79 42.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.938 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -45.61 92.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.893 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.54 -28.57 18.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 179.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.706 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.99 -31.61 70.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.838 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -38.78 11.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.563 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -50.79 5.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 109.53 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -63.43 -20.68 63.7 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.492 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . . . . . . 0 CA--C 1.518 0.265 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.7 m -82.35 -53.35 6.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.181 0.515 . . . . 0.0 110.734 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -49.98 -45.58 51.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.344 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.883 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.11 -30.41 65.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.718 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.883 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.6 tp -73.06 -47.45 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.044 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mt -80.51 -46.58 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.539 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -66.13 -43.22 93.68 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 14.0 t80 -66.66 -32.85 74.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.094 0.474 . . . . 0.0 109.86 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 4.4 m-30 -75.35 -30.3 60.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.947 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.07 -28.97 57.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 46' ' ' GLY . 2.5 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.58 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 23.2 m-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.979 0.419 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 tp -75.61 -52.36 10.75 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.427 0.632 . . . . 0.0 110.083 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -52.36 -16.76 0.93 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.746 178.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -77.58 -63.07 1.46 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.793 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.26 -34.29 77.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.821 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 19' ' ' LEU . 40.3 t -65.5 -34.14 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.658 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.58 -26.9 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -42.3 99.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.959 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 pt20 -91.07 -28.9 17.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.088 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.749 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.967 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.5 ttm -93.45 -41.66 9.68 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.09 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HE3' ' N ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -93.62 -39.75 10.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.413 0.625 . . . . 0.0 110.41 -178.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -80.72 -8.2 87.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.846 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 45' ' ' ILE . 25.8 m -81.61 -53.77 5.97 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.061 0.458 . . . . 0.0 111.218 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.887 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.31 -44.07 54.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.603 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.93 -31.51 66.42 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.896 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.6 tp -73.21 -49.99 24.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.389 0.614 . . . . 0.0 110.691 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 41' ' ' THR . 31.2 mt -81.01 -52.14 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.141 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -60.58 -28.88 68.42 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 28.5 t80 -79.66 -32.98 41.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.061 0.458 . . . . 0.0 110.014 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -31.92 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -29.87 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.648 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 46' ' ' GLY . 33.7 m . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.509 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.894 0.378 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.11 146.73 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' C ' HG23 ' A' ' 6' ' ' ILE . 24.2 p-10 -179.37 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.986 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.55 129.72 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p 44.36 37.79 2.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.841 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.549 HG23 ' C ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -66.8 133.46 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 111.377 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -161.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -149.71 113.99 5.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.875 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.61 -88.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -90.35 -89.34 0.16 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.742 HD22 ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -131.83 5.39 4.25 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.405 ' N ' HD13 ' A' ' 11' ' ' LEU . 14.2 p-10 -105.84 178.58 4.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.801 0.334 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -51.4 -88.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' H ' HG23 ' A' ' 13' ' ' THR . 3.4 p-10 172.41 62.33 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.605 0.241 . . . . 0.0 110.934 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 5.5 Cg_exo -77.31 -16.27 15.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.721 2.28 . . . . 0.0 112.382 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.1 -56.73 3.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.728 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.89 ' O ' HD12 ' A' ' 21' ' ' LEU . 77.9 m -61.79 -27.65 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.839 0.352 . . . . 0.0 110.61 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 40.9 t30 -61.79 -66.58 0.52 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.496 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.2 tt -75.56 -37.63 59.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -64.66 -39.74 94.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.35 -18.14 53.05 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.142 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.848 ' N ' HD13 ' A' ' 21' ' ' LEU . 5.6 t90 -84.43 -42.91 15.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 19' ' ' LEU . 69.1 t -63.22 -32.7 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.213 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.63 -26.67 41.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.755 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -61.41 -42.77 99.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.1 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.61 -29.7 17.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.68 0.752 . . . . 0.0 109.714 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.637 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.92 -31.85 69.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.181 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.1 ttp -93.01 -41.2 10.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.087 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HE2' ' CD1' ' A' ' 25' ' ' PHE . 9.5 mtpt -91.4 -58.16 2.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -51.76 -27.2 19.27 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.859 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -76.38 -26.58 55.78 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.699 0.285 . . . . 0.0 111.314 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.87 -7.37 70.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.973 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.708 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.1 t-105 -83.95 -72.14 0.48 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.837 0.319 . . . . 0.0 110.981 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.29 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.849 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . -56.76 -49.04 73.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.878 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.528 ' O ' ' HA3' ' A' ' 40' ' ' GLY . . . -85.06 -31.67 22.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.75 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' TRP . 66.7 t -75.37 -55.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.367 0.603 . . . . 0.0 110.37 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.453 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 9.8 t80 -73.82 -58.54 3.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.961 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -69.1 -41.84 76.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.877 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -58.24 -29.36 62.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.148 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.8 m -84.54 -47.09 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 38' ' ' PHE . 14.7 mt -58.66 -40.77 84.44 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.767 0.318 . . . . 0.0 110.63 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.76 -28.67 63.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.9 tp -72.39 -39.23 68.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.005 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.63 -49.56 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.94 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.668 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -63.64 -27.45 71.02 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.793 ' O ' HG23 ' A' ' 51' ' ' VAL . 10.8 t80 -86.37 -33.02 20.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.2 m-85 -76.56 -31.54 57.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.96 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -81.4 -29.59 33.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.55 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' GLY . 28.3 m -78.21 -34.77 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.297 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 47' ' ' PHE . 93.7 t -70.54 -31.68 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.757 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.532 ' HA2' ' HG2' ' A' ' 56' ' ' PRO . . . -94.16 14.92 64.32 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.569 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -118.23 -17.04 9.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.581 0.229 . . . . 0.0 111.595 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 74.9 mmm -140.6 34.06 1.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -145.3 -64.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.6 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 21.3 Cg_exo -60.93 -17.82 53.53 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.496 1.464 . . . . 0.0 110.401 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.662 HG12 ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -60.09 -52.92 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.208 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.662 ' N ' HG12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -93.15 -44.31 8.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.496 0.665 . . . . 0.0 110.93 178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -32.3 71.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.779 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -113.13 -6.33 13.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.48 178.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.6 mp0 53.47 24.66 4.15 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.978 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.839 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -129.67 136.74 29.56 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.248 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.523 ' C ' ' HD2' ' A' ' 65' ' ' PRO . 58.1 Cg_endo -74.26 -88.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.473 2.115 . . . . 0.0 113.131 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -89.6 -14.23 0.2 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.839 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 95.1 Cg_exo -43.76 -28.43 1.96 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.148 1.899 . . . . 0.0 112.714 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -120.44 130.31 54.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.737 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.07 -160.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.967 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 48' ' ' PHE . 69.3 p -79.83 -78.59 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.636 0.255 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' N ' ' OG1' ' A' ' 68' ' ' THR . . . 55.12 26.63 43.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.561 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.376 . . . . 0.0 111.163 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.794 0.33 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.87 160.14 39.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.73 173.65 11.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.57 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.5 ' C ' HG22 ' A' ' 5' ' ' THR . 10.0 ptmm? -62.82 129.27 39.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.33 . . . . 0.0 110.609 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.5 HG22 ' C ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER 159.78 -53.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.43 ' H ' HG23 ' A' ' 5' ' ' THR . 21.5 pt -92.0 -178.69 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 9' ' ' ASP . 8.1 p90 -129.61 31.39 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 44.37 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.651 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' PHE . 36.5 t70 -115.53 -75.84 0.58 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.722 0.296 . . . . 0.0 110.994 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -59.61 141.37 55.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.774 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -68.58 -121.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.348 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.51 ' N ' HD13 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -49.57 -41.0 40.47 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -87.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.189 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER 44.43 85.07 0.18 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.344 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.59 -25.77 76.1 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.696 2.264 . . . . 0.0 112.448 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 11.4 tptp -90.34 -16.85 28.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.121 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.776 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 4.7 m -91.92 -55.7 3.36 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.58 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -52.95 -66.57 0.36 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.76 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -75.78 -42.59 49.77 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.131 0.491 . . . . 0.0 111.15 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.657 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -71.82 -31.72 66.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.748 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.902 HD13 ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -79.55 -22.49 43.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.419 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.902 ' N ' HD13 ' A' ' 21' ' ' LEU . 40.5 t90 -82.21 -48.36 11.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 19' ' ' LEU . 12.0 p -65.31 -30.67 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.333 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -83.5 -26.8 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -58.23 -38.88 77.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.712 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.13 -30.57 16.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.476 0.655 . . . . 0.0 110.519 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.585 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -68.73 -34.96 76.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.823 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -34.88 13.17 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.59 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 7.5 ttpp -98.22 -33.89 10.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -84.24 -9.27 82.34 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -90.38 -53.61 4.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.67 0.271 . . . . 0.0 111.612 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.23 -40.16 34.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.8 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 37' ' ' VAL . 7.6 t90 -79.33 -69.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.63 0.253 . . . . 0.0 111.322 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -61.78 -57.98 9.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.253 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -29.53 -46.4 0.09 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.727 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.01 10.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.503 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 33' ' ' TRP . 28.9 t -75.25 -55.41 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.273 0.559 . . . . 0.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.425 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -64.73 -58.29 6.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.201 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 3.1 t80 -59.84 -43.25 94.71 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.039 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.73 -32.19 39.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.197 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.4 m -82.39 -52.19 7.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.844 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' GLY . 58.2 mt -57.45 -36.59 71.61 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.444 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.19 -30.74 65.25 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.908 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.1 tp -73.06 -50.06 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 mt -82.92 -46.35 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.012 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.929 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -64.41 -34.32 89.6 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 21.7 t80 -76.69 -33.17 58.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.207 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.752 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -75.46 -32.9 60.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.531 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -29.46 66.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.929 HG23 ' O ' ' A' ' 46' ' ' GLY . 14.0 t -78.33 -30.63 15.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.358 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 48' ' ' PHE . 2.4 p -62.46 -27.91 43.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.795 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.06 -5.43 56.29 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.621 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -137.14 50.13 2.0 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.741 0.305 . . . . 0.0 111.271 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.745 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 169.82 28.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.87 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.574 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.65 -65.4 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 37.7 Cg_exo -57.41 -17.37 26.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.312 1.342 . . . . 0.0 110.255 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -81.87 -52.3 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.563 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.625 ' H ' HD13 ' A' ' 57' ' ' ILE . 5.5 pt20 -90.34 -18.17 26.03 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.5 tt0 -63.08 -24.03 67.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.62 -9.69 59.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.491 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 65.34 17.76 11.1 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.042 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.849 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -153.21 165.3 17.97 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.641 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 56.8 Cg_endo -70.08 -94.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.295 1.997 . . . . 0.0 112.801 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.73 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -83.68 -22.89 0.32 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.849 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 75.1 Cg_exo -46.24 153.85 0.97 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.266 1.977 . . . . 0.0 112.606 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -169.82 -61.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 mt 67.37 -71.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 t -160.01 -161.36 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.796 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.58 138.42 10.63 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.743 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.195 -179.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.847 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.67 120.89 24.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -175.53 -68.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -59.74 -169.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 5' ' ' THR . 10.1 t -91.29 74.37 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.4 mp -100.36 -59.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.492 ' HE2' ' HG1' ' A' ' 17' ' ' THR . 17.7 t80 -167.71 138.1 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.988 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.21 135.78 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.42 -29.87 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -59.62 -25.29 64.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.19 -2.89 33.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.619 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 72.23 -152.02 0.08 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.426 0.155 . . . . 0.0 110.684 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -41.27 149.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 111.57 -179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 4.6 t-20 -77.13 -46.98 2.71 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 60.5 Cg_exo -51.03 -25.22 15.82 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.187 1.924 . . . . 0.0 112.431 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.4 tmpt? -56.49 -32.82 65.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.774 ' O ' HD23 ' A' ' 21' ' ' LEU . 82.5 m -90.52 -55.18 3.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.015 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 8.8 m-80 -56.26 -35.01 66.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.458 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.9 tt -75.85 -52.85 9.47 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.292 0.568 . . . . 0.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -53.48 -16.18 1.37 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.817 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.774 HD23 ' O ' ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.15 -62.86 1.51 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.155 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -64.47 -43.27 94.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.837 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 19' ' ' LEU . 22.0 t -56.58 -35.58 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.731 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 28' ' ' MET . . . -79.68 -26.74 40.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.6 -37.47 78.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.61 -41.78 10.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 111.63 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -69.21 -39.57 78.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.39 -179.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -92.68 -41.83 9.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.751 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 23.8 mtmt -97.08 -29.72 13.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.484 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -87.7 -5.2 78.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -86.46 -60.02 2.11 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.777 0.322 . . . . 0.0 111.706 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.29 -20.85 79.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.049 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.607 ' O ' HG23 ' A' ' 37' ' ' VAL . 55.6 t-105 -78.5 -70.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.714 0.292 . . . . 0.0 111.242 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -57.09 -59.94 4.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.28 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -27.75 -48.28 0.06 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.975 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.52 -39.96 10.35 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.511 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 33' ' ' TRP . 24.4 t -75.28 -55.27 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.159 0.504 . . . . 0.0 111.041 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -65.3 -56.05 14.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.167 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 38' ' ' PHE . 4.5 t80 -61.4 -41.94 97.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.752 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -54.4 -31.73 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.396 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.475 HG22 HD12 ' A' ' 45' ' ' ILE . 5.0 m -84.39 -47.06 11.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.53 0.205 . . . . 0.0 110.622 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 42' ' ' LEU . 1.8 mt -58.87 -34.97 72.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.22 -33.05 67.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -73.0 -44.06 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.462 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 41' ' ' THR . 12.4 mt -89.22 -42.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -67.29 -30.47 75.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.886 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -83.45 -33.1 25.73 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 109.894 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.712 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -77.1 -31.47 55.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.905 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -76.63 -29.77 56.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.56 -30.86 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 47' ' ' PHE . 64.9 t -63.45 -18.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.751 -0.38 . . . . 0.0 109.992 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.33 -11.35 29.57 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.363 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -115.89 30.27 7.45 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.104 0.452 . . . . 0.0 111.258 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.711 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -179.56 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.534 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.579 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -147.38 -61.91 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 17.5 Cg_exo -64.11 -17.69 60.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.794 1.663 . . . . 0.0 110.005 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.738 HD13 ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -80.4 -41.41 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.738 ' N ' HD13 ' A' ' 57' ' ' ILE . 16.1 pt20 -90.19 -15.97 30.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 1.3 mt-10 -58.7 -24.49 61.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.338 0.589 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -22.78 66.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.998 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 61.94 28.6 17.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.062 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 65' ' ' PRO . . . -122.89 122.18 27.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.085 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.13 -93.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.23 1.954 . . . . 0.0 112.383 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.668 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -59.67 -46.44 98.56 Favored Pre-proline 0 CA--C 1.53 0.193 0 O-C-N 122.471 -0.143 . . . . 0.0 111.229 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HB2' ' HB1' ' A' ' 62' ' ' ALA . 81.6 Cg_exo -33.32 -60.99 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.215 2.61 . . . . 0.0 113.424 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -168.08 86.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tp -78.27 -30.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 69' ' ' GLY . 9.0 t -124.63 -45.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 68' ' ' THR . . . 70.32 -129.1 19.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 111.051 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.754 0.311 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.92 159.19 17.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 -167.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.66 137.69 32.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.86 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.14 32.72 21.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.774 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 6' ' ' ILE . 6.2 tt -155.65 52.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 111.181 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.92 37.07 1.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.679 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -108.99 33.16 4.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -94.82 -53.48 3.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -89.81 -60.23 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -151.59 -179.18 7.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -63.43 -68.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.766 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -57.66 168.63 0.83 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -172.58 67.05 0.38 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.56 -25.22 48.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.494 2.129 . . . . 0.0 111.912 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.77 -27.23 64.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.038 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.858 ' O ' HD21 ' A' ' 21' ' ' LEU . 30.2 m -74.61 -21.04 59.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.187 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.715 ' HA ' HD21 ' A' ' 21' ' ' LEU . 37.9 m-20 -97.96 -42.43 7.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.865 0.364 . . . . 0.0 111.947 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.947 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -75.16 -32.73 61.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.503 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.636 ' NH2' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -64.96 -33.61 76.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.858 HD21 ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -83.46 -30.78 26.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.265 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.94 -44.71 76.2 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 19' ' ' LEU . 52.6 t -64.48 -33.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.195 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -79.62 -26.78 41.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -43.44 89.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.67 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -89.68 -28.47 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.431 0.634 . . . . 0.0 110.14 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -68.42 -31.89 71.55 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.528 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 ttp -92.55 -33.4 14.46 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.097 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.95 -18.99 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.141 0.496 . . . . 0.0 110.19 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -103.33 -9.67 38.19 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.943 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.647 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -96.11 -45.56 6.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 0.0 111.651 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.73 -47.83 9.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -63.65 -56.69 13.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.263 . . . . 0.0 111.338 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -53.1 -61.85 2.03 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.409 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -22.7 -53.78 0.02 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.972 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.72 -44.16 9.52 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.738 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -75.31 -55.3 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.222 0.534 . . . . 0.0 111.062 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -59.51 -58.63 7.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.054 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 2.7 t80 -53.6 -43.72 68.85 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.258 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -54.55 -31.26 52.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.603 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 45' ' ' ILE . 12.9 m -85.64 -45.05 12.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.823 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 38' ' ' PHE . 9.7 mt -60.9 -35.9 77.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 110.523 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.56 -31.88 65.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.989 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 tp -72.45 -45.23 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.507 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 41' ' ' THR . 8.9 mt -85.7 -41.8 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -68.62 -31.15 73.15 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.646 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 42.0 t80 -79.95 -32.44 39.98 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.91 0.386 . . . . 0.0 110.467 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.615 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -76.37 -51.98 10.82 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -29.72 68.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -80.16 -33.79 14.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.173 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -60.41 -21.85 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.408 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.54 -9.26 31.39 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.247 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.4 41.55 3.49 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.974 0.387 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.683 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 170.53 31.45 0.0 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.619 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.558 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.96 -65.49 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 38.9 Cg_exo -55.69 -17.58 18.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.29 1.327 . . . . 0.0 110.235 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -81.26 -55.26 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.57 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.615 ' H ' HD13 ' A' ' 57' ' ' ILE . 10.1 pt20 -91.01 -18.16 25.08 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.4 tp10 -60.58 -22.46 63.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.35 -27.95 69.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.884 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 55.96 32.96 20.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.259 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 65' ' ' PRO . . . -151.91 121.98 3.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 56.8 Cg_endo -81.54 -82.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.319 2.013 . . . . 0.0 113.061 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.707 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -68.02 -29.3 2.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 38.5 Cg_exo -56.89 -147.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.614 2.209 . . . . 0.0 112.172 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 4.3 m-80 74.01 -67.71 0.25 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 66' ' ' ASN . 2.5 pp -156.86 -179.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.444 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.403 ' O ' HD12 ' A' ' 67' ' ' ILE . 16.8 p -79.89 137.6 36.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.845 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.38 138.92 3.47 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.449 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.095 179.949 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.42 142.35 33.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.55 -76.38 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -89.96 -177.9 5.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 5' ' ' THR . 10.6 t -86.61 55.86 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.973 0.416 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.8 pt -122.34 9.4 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.44 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 57.6 57.61 4.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 61.52 -164.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -49.58 -53.39 24.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.126 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -61.42 118.08 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.7 pt? -125.02 -164.31 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.788 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.51 -64.32 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 t -88.76 86.5 6.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -133.75 66.65 73.57 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.68 -25.05 57.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 112.514 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -74.67 -33.8 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 111.039 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.929 ' O ' HD12 ' A' ' 21' ' ' LEU . 84.9 m -90.18 -21.91 21.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.32 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.56 -66.98 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.884 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.92 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.72 -52.88 8.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.824 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.89 -31.94 73.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.937 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.21 -26.19 42.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.692 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.894 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.7 t90 -82.28 -37.7 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.5 t -63.5 -37.14 78.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.611 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.61 -26.79 41.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -63.28 -35.67 81.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.209 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.59 -40.28 11.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.222 0.534 . . . . 0.0 111.108 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.2 -43.22 67.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.339 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.6 ttp -92.35 -41.73 10.19 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.551 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.812 ' HB3' ' O ' ' A' ' 25' ' ' PHE . 1.7 ttpt -96.07 -32.38 12.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -85.01 -4.13 87.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.38 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -88.2 -59.6 2.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.37 62.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.012 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.413 ' CE3' ' HA ' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -82.34 -69.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 111.362 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -47.69 -28.64 2.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.68 -57.54 13.84 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.023 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.76 -31.18 24.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t -75.35 -55.11 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.215 0.531 . . . . 0.0 110.722 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -71.65 -58.16 3.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.853 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -63.0 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.63 -31.18 66.7 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.14 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 m -82.5 -46.21 13.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 0.0 110.415 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 39' ' ' PHE . 5.2 mt -60.4 -38.09 82.89 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.92 -28.9 63.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.898 ' N ' HD23 ' A' ' 43' ' ' LEU . 4.6 tp -72.85 -44.79 60.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.945 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 mt -87.85 -49.5 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.29 -24.33 65.36 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.565 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.5 t80 -88.86 -33.05 17.48 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.975 0.417 . . . . 0.0 110.106 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -32.86 64.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -79.61 -34.12 40.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.713 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 46' ' ' GLY . 29.1 m -80.39 -30.69 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.376 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 47' ' ' PHE . 78.7 t -74.94 -29.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 13.6 65.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.507 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 49' ' ' ARG . 29.5 tpt85 -122.23 -15.26 7.74 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.463 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.45 45.57 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.634 HD23 ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -153.89 -66.84 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.634 ' HD3' HD23 ' A' ' 55' ' ' LEU . 36.5 Cg_exo -52.53 -17.84 7.39 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.663 1.575 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.747 HG12 ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -67.46 -57.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.685 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.747 ' N ' HG12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -92.91 -37.38 12.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.9 -28.45 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.932 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -113.69 -16.57 12.29 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.296 178.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER 54.1 23.01 3.82 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.807 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.763 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -153.01 167.98 12.35 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 19.2 Cg_endo -58.75 -160.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.467 2.111 . . . . 0.0 112.351 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.647 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -66.68 -27.17 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 84.2 Cg_exo -46.35 99.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.423 2.082 . . . . 0.0 112.696 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -173.51 174.12 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.58 137.47 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.46 169.16 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.799 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.78 76.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.516 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.777 0.323 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.34 150.37 49.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 75.03 -62.47 0.45 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.516 ' C ' HG23 ' A' ' 5' ' ' THR . 4.1 pttt -80.79 141.89 34.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.671 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.516 HG23 ' C ' ' A' ' 4' ' ' LYS . 1.1 p 70.21 10.66 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.472 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 tt -162.6 147.41 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.752 0.31 . . . . 0.0 111.154 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -57.91 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.52 150.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.878 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.25 169.19 5.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -68.4 71.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.96 69.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.524 ' O ' HG22 ' A' ' 13' ' ' THR . 54.4 t-20 62.1 110.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER 72.59 178.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.547 ' N ' HG23 ' A' ' 13' ' ' THR . 2.2 t-20 173.1 -47.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.765 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HB2' HD22 ' A' ' 19' ' ' LEU . 39.4 Cg_exo -60.94 -10.04 13.67 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.418 2.079 . . . . 0.0 112.56 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -49.21 -27.09 3.35 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.033 0.444 . . . . 0.0 111.078 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.921 ' O ' HD21 ' A' ' 21' ' ' LEU . 31.6 m -91.64 -22.71 20.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.669 ' O ' HD22 ' A' ' 21' ' ' LEU . 4.8 m-80 -101.57 -57.8 2.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.25 -31.29 62.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.304 -178.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.04 -38.96 92.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.921 HD21 ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.02 -23.1 44.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.738 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.471 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -76.96 -55.23 5.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 19' ' ' LEU . 44.4 t -57.45 -29.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.34 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' ' CG ' ' A' ' 27' ' ' MET . . . -78.35 -26.08 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.097 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' CA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -71.37 -30.27 65.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.099 -179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -91.87 -37.48 12.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 112.037 -179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.763 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -65.32 -37.19 86.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.298 0.571 . . . . 0.0 111.163 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.7 ttp -92.71 -41.59 10.07 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.113 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HE2' ' CA ' ' A' ' 25' ' ' PHE . 3.2 mtmm -95.4 -43.99 7.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.115 0.483 . . . . 0.0 110.096 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 26' ' ' GLN . . . -70.63 -13.14 71.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.114 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -77.8 -45.76 23.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.766 0.317 . . . . 0.0 111.547 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.77 -35.05 66.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.709 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -71.47 -71.97 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.604 0.24 . . . . 0.0 111.32 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.73 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -45.82 -58.76 3.24 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.439 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -23.74 -50.64 0.02 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.565 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -78.82 -47.99 7.41 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.389 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 t -75.15 -55.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.378 0.609 . . . . 0.0 110.991 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.73 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -55.64 -58.08 9.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.022 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 1.1 t80 -53.95 -43.16 69.63 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.172 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . -54.75 -31.25 53.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.347 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.456 HG22 HD12 ' A' ' 45' ' ' ILE . 11.1 m -84.61 -48.28 9.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.684 0.278 . . . . 0.0 110.703 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD11 ' CD2' ' A' ' 38' ' ' PHE . 22.2 mt -58.66 -36.64 74.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.14 -31.9 66.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.925 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.63 -45.87 56.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.87 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 41' ' ' THR . 15.9 mt -87.73 -48.57 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 50' ' ' VAL . . . -62.67 -28.79 72.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -84.86 -33.26 22.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -73.05 -35.9 66.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -75.72 -32.85 60.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.408 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' GLY . 9.8 p -80.74 -30.13 11.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.469 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 47' ' ' PHE . 66.0 t -68.38 -9.73 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.94 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.77 -14.53 9.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.444 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 54' ' ' MET . 3.6 ttt85 -105.55 3.84 29.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.144 0.472 . . . . 0.0 111.757 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.639 ' HA ' HD12 ' A' ' 57' ' ' ILE . 3.6 mmt -163.57 47.66 0.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.802 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -151.77 -61.82 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 35.9 Cg_exo -58.6 -17.6 35.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 121.629 1.553 . . . . 0.0 110.351 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -80.68 -50.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.137 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.601 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.8 -14.52 31.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.423 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -61.73 -20.84 63.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.012 0.434 . . . . 0.0 109.902 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -24.9 30.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.393 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 24.95 8.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.209 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.643 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . . . -73.15 136.64 79.09 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.917 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.96 -97.58 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.178 1.919 . . . . 0.0 112.173 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.696 ' N ' ' HD2' ' A' ' 65' ' ' PRO . . . -61.87 -46.12 92.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.388 0.137 . . . . 0.0 111.25 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 64' ' ' ALA . 76.2 Cg_exo -34.72 -34.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.248 2.632 . . . . 0.0 113.305 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 62' ' ' ALA . 13.7 m-20 -112.08 123.29 49.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.873 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.1 pt -61.49 144.94 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.4 m -87.76 125.82 34.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.03 -40.73 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.493 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.094 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.79 118.89 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -179.23 -78.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 170.06 10.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.756 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 6' ' ' ILE . 18.0 p -75.85 63.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 7' ' ' PHE . 3.0 mp 60.81 158.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.48 ' N ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.06 -167.39 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 62.54 96.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -137.02 -160.78 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.743 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.723 ' HB3' HD23 ' A' ' 11' ' ' LEU . 19.7 t-80 -44.9 -38.74 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.824 0.345 . . . . 0.0 111.474 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.723 HD23 ' HB3' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -135.13 160.49 38.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -81.47 60.83 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 13' ' ' THR . 8.7 t -100.99 78.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -132.42 67.54 78.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.75 -25.38 60.32 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.104 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -27.85 64.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -90.41 -55.24 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.684 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.674 ' HA ' HD21 ' A' ' 21' ' ' LEU . 9.2 m-80 -43.5 -43.96 5.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.048 0.451 . . . . 0.0 111.39 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 tp -74.04 -31.18 62.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.824 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -61.87 -39.49 92.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -79.44 -30.83 42.41 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.092 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 5.9 t90 -71.1 -41.13 70.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 19' ' ' LEU . 70.4 t -67.64 -31.58 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.147 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.7 -26.67 40.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.627 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -70.64 -31.72 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.722 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -92.06 -29.15 16.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.763 0.792 . . . . 0.0 109.798 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.698 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.03 -34.0 74.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.805 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.7 ttp -94.19 -40.18 10.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.148 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -95.08 -39.25 10.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.492 0.663 . . . . 0.0 110.625 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.82 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -79.34 -13.31 82.89 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.598 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -77.44 -55.66 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.32 -46.61 19.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.661 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -76.17 -69.83 0.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.575 0.226 . . . . 0.0 111.378 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -56.73 -54.06 50.58 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.056 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -27.86 -46.97 0.05 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.469 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -79.4 -46.85 7.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.917 -0.658 . . . . 0.0 113.357 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.2 t -75.18 -55.31 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.442 0.639 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.552 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -59.77 -58.0 10.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.399 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HA ' HD12 ' A' ' 42' ' ' LEU . 1.9 t80 -56.68 -41.62 77.63 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 43' ' ' LEU . . . -55.47 -34.04 59.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.626 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.477 HG22 HD12 ' A' ' 45' ' ' ILE . 10.4 m -83.08 -44.67 14.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.683 0.278 . . . . 0.0 110.635 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 39' ' ' PHE . 4.8 mt -60.82 -35.5 76.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.861 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.59 -30.32 64.28 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.914 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.3 tp -72.93 -50.18 25.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.028 0.442 . . . . 0.0 110.927 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 41' ' ' THR . 9.5 mt -81.48 -47.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.587 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -62.36 -23.56 64.64 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.795 ' O ' HG23 ' A' ' 51' ' ' VAL . 64.6 t80 -81.54 -33.7 31.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -32.55 39.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.75 -32.43 62.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.469 -179.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG12 ' SD ' ' A' ' 54' ' ' MET . 35.1 m -81.4 -27.64 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.192 0.52 . . . . 0.0 111.743 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 47' ' ' PHE . 67.0 t -80.77 -5.56 8.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.06 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.82 18.75 4.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 27.6 ttt-85 -155.58 -46.0 0.08 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.282 0.563 . . . . 0.0 110.883 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.678 ' HA ' HD12 ' A' ' 57' ' ' ILE . 35.9 mtp -109.97 59.27 0.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.97 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -155.27 -59.07 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 22.1 Cg_exo -62.84 -17.48 59.72 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.793 1.662 . . . . 0.0 110.226 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.694 HD13 ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -84.42 -38.09 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.585 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.694 ' N ' HD13 ' A' ' 57' ' ' ILE . 5.8 pt20 -90.07 -16.41 29.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.17 -24.05 66.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.354 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -67.86 -29.04 68.07 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.207 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.46 14.26 9.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.667 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -153.08 160.04 31.46 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.819 0.343 . . . . 0.0 111.336 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.549 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 27.5 Cg_endo -62.83 -162.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.418 2.079 . . . . 0.0 112.181 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.703 ' N ' ' CD ' ' A' ' 65' ' ' PRO . . . -70.86 -22.51 0.6 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.703 ' CD ' ' N ' ' A' ' 64' ' ' ALA . 23.1 Cg_exo -62.45 3.93 0.41 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.725 2.283 . . . . 0.0 113.491 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.75 66.0 0.34 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.925 0.393 . . . . 0.0 110.51 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.08 163.68 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.183 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -107.67 -31.04 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.93 177.37 14.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 0.0 111.066 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.29 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.628 ' O ' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -176.24 -165.22 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -78.86 129.9 35.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t 43.09 68.89 0.44 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.542 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.628 HD11 ' O ' ' A' ' 3' ' ' ASP . 0.9 OUTLIER -83.55 139.14 18.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.766 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HA ' HG21 ' A' ' 17' ' ' THR . 11.0 t80 -84.1 -108.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 48.67 -171.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.824 0.345 . . . . 0.0 111.104 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.06 -72.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' CD2' ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -60.68 -176.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.079 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -84.22 -168.12 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -69.51 85.3 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 p -147.07 -148.17 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.727 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -177.24 -52.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 CA-C-O 120.463 0.173 . . . . 0.0 111.238 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 84.7 Cg_exo -49.33 -24.15 8.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.975 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -68.95 -52.88 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 111.148 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.749 ' O ' HD23 ' A' ' 21' ' ' LEU . 89.0 m -90.57 -22.09 21.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.85 0.357 . . . . 0.0 111.407 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.42 -61.43 1.7 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.5 tp -76.1 -53.03 8.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.642 HH21 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -52.25 -17.99 1.36 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.816 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 17' ' ' THR . 1.2 mm? -77.94 -63.18 1.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.193 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 4.5 t90 -61.11 -44.48 97.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.845 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 19' ' ' LEU . 26.3 t -51.37 -31.84 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 27' ' ' MET . . . -79.42 -26.37 41.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.847 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.828 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.04 -29.35 70.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.551 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.15 -37.09 13.59 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.891 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.97 -36.66 23.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.261 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.4 ttp -91.9 -43.61 9.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.828 0.347 . . . . 0.0 111.205 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.828 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.3 mtmt -93.8 -31.18 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -88.13 0.59 84.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.41 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -88.93 -59.43 2.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.69 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.81 -36.21 42.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.129 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.853 ' CD1' HG21 ' A' ' 37' ' ' VAL . 48.6 t90 -73.42 -68.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' O ' ' C ' ' A' ' 35' ' ' GLY . . . -44.26 -73.27 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -18.03 -60.64 0.01 OUTLIER Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.031 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 -40.64 11.54 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.943 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.853 HG21 ' CD1' ' A' ' 33' ' ' TRP . 60.4 t -75.3 -55.41 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.16 0.505 . . . . 0.0 111.178 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -60.08 -58.39 8.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.079 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -69.65 -41.66 75.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.699 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 39' ' ' PHE . . . -57.54 -31.48 63.46 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.21 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 84.9 m -84.34 -46.25 11.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.243 . . . . 0.0 110.657 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 39' ' ' PHE . 3.1 mt -60.57 -38.58 85.05 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.893 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.94 -29.14 63.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.893 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.5 tp -72.95 -48.23 38.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.907 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.32 -48.17 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.329 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.985 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -62.26 -33.6 86.55 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.301 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.604 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -79.15 -32.82 44.43 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -40.03 49.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -28.88 67.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 46' ' ' GLY . 93.0 t -69.13 -46.4 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 47' ' ' PHE . 25.3 t -56.69 -30.26 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.222 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA2' ' HG2' ' A' ' 56' ' ' PRO . . . -87.94 3.78 85.79 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.453 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.19 4.42 15.53 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.633 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -156.18 30.62 0.34 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -147.76 -64.16 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.525 ' HG2' ' HA2' ' A' ' 52' ' ' GLY . 25.7 Cg_exo -57.65 -17.29 28.09 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.13 1.22 . . . . 0.0 109.763 176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -86.37 -55.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.386 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.63 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -91.28 -34.13 15.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' LEU . 21.7 tp10 -65.31 -31.06 71.99 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.113 0.483 . . . . 0.0 109.975 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -86.23 -24.15 26.15 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.363 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 51.16 26.25 2.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.86 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -148.21 173.2 4.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 60.6 Cg_endo -88.64 -88.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.803 2.335 . . . . 0.0 113.073 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' CD ' ' A' ' 65' ' ' PRO . . . -60.74 -61.66 7.53 Favored Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.625 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 4.8 Cg_exo -38.66 93.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.388 2.726 . . . . 0.0 112.965 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -139.95 -170.24 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -129.25 54.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 t -136.06 143.49 44.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.88 -79.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.5 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.827 0.346 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.94 157.25 45.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.626 ' O ' HG23 ' A' ' 6' ' ' ILE . 10.4 p-10 -140.88 178.39 7.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 m 69.86 -72.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 3' ' ' ASP . 30.5 pt 40.81 57.42 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.645 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.55 157.07 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -166.56 179.21 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.771 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.91 -162.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.674 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -50.97 95.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.078 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.8 165.26 16.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.852 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.58 -59.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -177.77 101.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.981 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -108.04 145.1 30.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.35 -34.69 81.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.556 2.171 . . . . 0.0 112.599 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.57 -58.6 5.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.436 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.659 ' O ' HD23 ' A' ' 21' ' ' LEU . 97.1 m -67.95 -30.21 69.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.839 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 1.1 m120 -51.21 -66.48 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.005 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.86 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.3 tt -76.17 -43.02 44.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.86 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 4.4 tpm_? -52.48 -29.97 27.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.673 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 22' ' ' TRP . 4.2 pp -78.7 -41.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.887 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.713 ' N ' HD12 ' A' ' 21' ' ' LEU . 24.5 t90 -61.96 -45.31 94.22 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 19' ' ' LEU . 13.0 t -60.28 -30.18 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.342 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.21 -26.79 42.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.938 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -45.61 92.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.893 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -90.54 -28.57 18.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 179.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.706 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.99 -31.61 70.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.838 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -38.78 11.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.563 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -50.79 5.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 109.53 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.81 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -63.43 -20.68 63.7 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.492 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 27' ' ' MET . . . -80.03 -57.18 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.61 -67.74 1.79 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.973 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -48.47 -64.22 0.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -51.43 -61.65 2.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.348 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 34' ' ' ALA . . . -23.36 -52.83 0.03 OUTLIER Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.891 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -79.45 -44.45 9.49 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.678 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 34' ' ' ALA . 22.0 t -74.68 -55.44 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.24 0.543 . . . . 0.0 111.209 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -61.96 -59.28 5.33 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.885 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.643 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 8.4 t80 -49.55 -39.64 35.46 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 122.252 -0.28 . . . . 0.0 111.191 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -52.04 -44.87 56.89 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.103 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.7 m -82.35 -53.35 6.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.181 0.515 . . . . 0.0 110.734 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -49.98 -45.58 51.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.344 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.883 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -72.11 -30.41 65.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.718 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.883 ' N ' HD23 ' A' ' 43' ' ' LEU . 3.6 tp -73.06 -47.45 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.044 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mt -80.51 -46.58 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.539 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -66.13 -43.22 93.68 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.0 t80 -66.66 -32.85 74.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.094 0.474 . . . . 0.0 109.86 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 4.4 m-30 -75.35 -30.3 60.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.947 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HG2' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.07 -28.97 57.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 46' ' ' GLY . 2.5 t -80.25 -29.86 12.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.58 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 47' ' ' PHE . 21.8 t -72.5 -12.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.864 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.42 4.36 13.5 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.24 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 ttt-85 -158.74 41.49 0.24 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.961 0.381 . . . . 0.0 111.732 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.742 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 167.8 48.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.919 -179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -154.63 -60.54 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 23.4 Cg_exo -61.95 -17.83 57.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.744 1.629 . . . . 0.0 110.302 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.787 HD13 ' H ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -80.42 -38.86 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.315 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.787 ' H ' HD13 ' A' ' 57' ' ' ILE . 7.0 pt20 -90.27 -12.27 38.38 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.979 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -25.74 59.56 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.77 -20.75 62.06 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.239 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 73.05 31.51 1.47 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.902 ' HB1' ' HG2' ' A' ' 65' ' ' PRO . . . -153.13 132.28 6.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.26 -77.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.373 2.049 . . . . 0.0 112.277 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.745 ' N ' ' HD3' ' A' ' 65' ' ' PRO . . . -145.72 45.13 0.46 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.902 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 4.5 Cg_endo -87.77 -16.86 2.83 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.915 2.41 . . . . 0.0 112.031 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -101.94 129.28 48.17 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.238 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -103.19 145.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.9 -84.89 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.703 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.26 98.67 0.01 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.623 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.777 0.322 . . . . 0.0 111.018 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.838 0.351 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.12 175.02 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.92 -178.23 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 173.04 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.84 -65.66 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -70.72 152.92 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -53.79 149.05 9.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -70.5 -46.71 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 68.5 72.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -48.42 77.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.11 -60.61 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.64 37.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.616 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.05 95.81 5.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 3.7 t30 -79.65 -34.89 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.964 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 14' ' ' ASN . 88.7 Cg_exo -48.4 -23.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.302 2.001 . . . . 0.0 112.816 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.95 -27.41 7.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 110.902 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.8 m -90.38 -55.48 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 23.2 m-20 -46.89 -35.47 6.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.121 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 tp -75.61 -52.36 10.75 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.427 0.632 . . . . 0.0 110.083 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -52.36 -16.76 0.93 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.746 178.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -77.58 -63.07 1.46 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.793 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.26 -34.29 77.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.821 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 19' ' ' LEU . 40.3 t -65.5 -34.14 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.658 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 27' ' ' MET . . . -79.58 -26.9 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -42.3 99.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.959 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 pt20 -91.07 -28.9 17.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.088 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.749 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.967 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.5 ttm -93.45 -41.66 9.68 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.09 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HE3' ' N ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -93.62 -39.75 10.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.413 0.625 . . . . 0.0 110.41 -178.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 34' ' ' ALA . . . -80.72 -8.2 87.75 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.846 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 27' ' ' MET . . . -82.37 -60.14 2.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.57 -33.82 33.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.948 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -90.2 -65.95 0.97 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HB3' ' HA2' ' A' ' 30' ' ' GLY . . . -65.72 -34.11 77.44 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 111.009 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . -50.56 -60.35 6.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.314 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 -40.14 14.06 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.38 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 33' ' ' TRP . 39.8 t -74.55 -55.37 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.144 0.497 . . . . 0.0 111.456 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' N ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -66.19 -59.46 3.74 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.522 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.69 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 23.4 t80 -44.7 -45.2 9.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.065 0.393 . . . . 0.0 111.414 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 43' ' ' LEU . . . -49.52 -48.6 34.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.448 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 HD12 ' A' ' 45' ' ' ILE . 25.8 m -81.61 -53.77 5.97 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.061 0.458 . . . . 0.0 111.218 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.887 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.31 -44.07 54.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.603 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.93 -31.51 66.42 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.896 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.6 tp -73.21 -49.99 24.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.389 0.614 . . . . 0.0 110.691 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 41' ' ' THR . 31.2 mt -81.01 -52.14 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.141 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' HG13 ' A' ' 50' ' ' VAL . . . -60.58 -28.88 68.42 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.846 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.5 t80 -79.66 -32.98 41.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.061 0.458 . . . . 0.0 110.014 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -31.92 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -29.87 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.648 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 46' ' ' GLY . 33.7 m -81.12 -28.55 10.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.509 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 47' ' ' PHE . 65.0 t -74.66 -12.23 14.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.529 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.82 21.19 4.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.021 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -172.98 28.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.696 0.284 . . . . 0.0 111.542 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.844 ' HA ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER 179.82 40.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.134 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -147.48 -64.72 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 55' ' ' LEU . 27.7 Cg_exo -57.45 -17.55 27.87 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.266 1.311 . . . . 0.0 109.849 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.988 HD13 ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.65 -35.93 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.948 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.988 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -90.39 -16.64 28.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.638 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -68.39 -18.32 64.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.81 23.85 6.68 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.413 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 70.48 143.8 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.433 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -54.26 157.52 4.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.379 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 57.0 Cg_endo -70.78 71.48 2.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.622 2.215 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB3' ' CD ' ' A' ' 65' ' ' PRO . . . -176.63 -62.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.379 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.605 ' CD ' ' HB3' ' A' ' 64' ' ' ALA . 2.5 Cg_endo -45.08 -51.77 7.23 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.847 2.365 . . . . 0.0 112.692 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -108.79 -29.98 8.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.068 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.12 62.98 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -131.87 -47.39 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.824 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.27 27.42 30.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.547 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 111.031 -179.988 . . . . . . . . 0 0 . 1 stop_ save_